Phase 3 readouts expected in 2027

Every Phase 3 and Phase 2/3 study on a drug AssetMemo covers whose estimated primary completion date falls in 2027, by month. The primary completion date is the sponsor's estimate of when the last participant is assessed for the primary endpoint, so it is the nearest public marker of a readout, not a confirmed date. Dates move: recent moves are on the delayed readouts page, and every phase is on the readout calendar.

Summary

839 studies (738 Phase 3, 101 Phase 2/3) across 503 drugs.

January 2027

Primary completionDrugDeveloperIndicationPhaseStudy
2027-01 (month only)RituximabBiogen, Chugai Pharma, RochePolymyalgia RheumaticaPhase 3NCT05533164
2027-01 (month only)TapinarofOrganon, Shionogi, Torii PharmaceuticalPsoriasisPhase 2/3NCT05981118
2027-01 (month only)TicagrelorAstraZenecaChronic Coronary DiseasePhase 3NCT05997693
2027-01 (month only)BudigalimabAbbVieHepatocellular CarcinomaPhase 2/3NCT06109272
2027-01 (month only)Sotagliflozin (Inpefa)Lexicon Pharmaceuticals, ViatrisHypertrophic CardiomyopathyPhase 3NCT06481891
2027-01 (month only)Ivonescimab, LigufalimabAkeso, Summit TherapeuticsHead and Neck Squamous Cell CarcinomaPhase 3NCT06601335
2027-01 (month only)setrusumabMereo BioPharma, Ultragenyx Pharmaceutical Inc.Osteogenesis ImperfectaPhase 3NCT06636071
2027-01 (month only)upadacitinibAbbVieAtopic DermatitisPhase 3NCT06701331
2027-01 (month only)Montelukast (Singulair)OrganonDengue, Montelukast, TransaminasesPhase 2/3NCT06747130
2027-01 (month only)Semaglutide (Ozempic), EmpagliflozinNovo Nordisk, Boehringer Ingelheim, Eli LillyDiabetes Type 1Phase 3NCT06894784
2027-01 (month only)AzetukalnerXenon PharmaceuticalsMajor Depressive DisorderPhase 3NCT06922110
2027-01 (month only)crisaborolePfizerAtopic DermatitisPhase 3NCT07162896
2027-01 (month only)DapagliflozinAstraZeneca, Ono PharmaceuticalSTEMI - ST Elevation Myocardial Infarction, Epicardial FatPhase 3NCT07297589
2027-01 (month only)LacosamideUCBBipolar Affective DisorderPhase 3NCT07412132
2027-01 (month only)VormatriginePraxis Precision Medicines, Inc.Epilepsy, Focal Onset SeizuresPhase 3NCT07505004
2027-01 (month only)RSS0393Jiangsu Hengrui Pharmaceuticals, Reistone BiopharmaPsoriasisPhase 3NCT07543224
2027-01-01PembrolizumabMerck & Co.Urothelial CarcinomaPhase 3NCT03244384
2027-01-01Sacubitril/valsartanNovartis, Otsuka HoldingsHypertensionPhase 2/3NCT04971720
2027-01-01Naloxone (Narcan)Emergent BioSolutionsOpioid-use DisorderPhase 2/3NCT05011266
2027-01-01guselkumab, ustekinumab, adalimumab, dupilumab, fluticasone propionate, SarilumabJohnson & Johnson, AbbVie, Regeneron PharmaceuticalsSkin Inflammation, Allergic Contact DermatitisPhase 2/3NCT05535738
2027-01-01SelinexorA. Menarini, Antengene Corporation Limited, FORUS Therapeutics Inc.Lymphohistiocytosis, EBV, CAEBVPhase 2/3NCT07369739
2027-01-04sonelokimabMoonLake ImmunotherapeuticsPsoriatic ArthritisPhase 3NCT06641089
2027-01-04LaroprovstatAstraZenecaAtherosclerotic Cardiovascular DiseasePhase 3NCT07000136
2027-01-06AnifrolumabAstraZeneca, MedImmune LLCSystemic SclerosisPhase 3NCT05925803
2027-01-08Oleclumab, MonalizumabMedImmune LLC, Innate PharmaNon-Small Cell Lung CancerPhase 3NCT05221840
2027-01-08Axitinib intravitreal implant (OTX-TKI)OCULAR THERAPEUTIX, INCAge-Related Macular Degeneration, Wet Age-Related Macular DegenerationPhase 3NCT06495918
2027-01-09Trastuzumab EmtansineRocheHER2-Positive Breast Cancer, Breast CancerPhase 3NCT07673029
2027-01-10Mezigdomide, Bortezomib, DexamethasoneBristol-Myers Squibb, Janssen, Takeda Pharmaceutical CompanyMultiple MyelomaPhase 3NCT05519085
2027-01-11Osimertinib, Datopotamab Deruxtecan, pemetrexedAstraZeneca, Daiichi Sankyo, Eli LillyNon-Small Cell Lung CancerPhase 3NCT06417814
2027-01-11LaroprovstatAstraZenecaAtherosclerotic Cardiovascular DiseasePhase 3NCT07000123
2027-01-12Pembrolizumab, Sacituzumab GovitecanMerck & Co., Gilead SciencesNon-Small Cell Lung CancerPhase 3NCT05609968
2027-01-12infliximabJohnson & JohnsonSarcoidosisPhase 3NCT05689879
2027-01-12RituximabBiogen, Chugai Pharma, RocheLymphoma, Large B-Cell, DiffusePhase 3NCT06573645
2027-01-13tezepelumabAmgen, AstraZenecaChronic Rhinosinusitis With Nasal PolypsPhase 3NCT06706817
2027-01-13IvonescimabAkeso, Summit TherapeuticsMetastatic Colorectal CancerPhase 3NCT06951503
2027-01-14Amdokitug (Yisaituo)Sunshine Guojian PharmaceuticalAnkylosing SpondylitisPhase 3NCT07261644
2027-01-15Cemiplimab, FianlimabRegeneron PharmaceuticalsMelanomaPhase 3NCT05608291
2027-01-15Crizotinib, DarovasertibPfizer, IDEAYA Biosciences, ServierUveal MelanomaPhase 2/3NCT05987332
2027-01-16InclisiranAlnylam Pharmaceuticals, NovartisAtherosclerotic Cardiovascular DiseasePhase 3NCT07102628
2027-01-19Alectinib, EntrectinibChugai Pharma, RocheNon-Small Cell Lung CancerPhase 3NCT05170204
2027-01-21UblituximabNeuraxpharm, TG THERAPEUTICS, INC.Multiple SclerosisPhase 3NCT05877963
2027-01-21maridebart cafraglutideAmgenObesity, Type 2 DiabetesPhase 3NCT06858839
2027-01-21maridebart cafraglutideAmgenObesity, Type 2 DiabetesPhase 3NCT06858878
2027-01-25SuzetrigineVertex PharmaceuticalsDiabetic Peripheral Neuropathic PainPhase 3NCT06696443
2027-01-25insulin icodecNovo NordiskDiabetes Mellitus, Type 1Phase 3NCT07076199
2027-01-26fluticasone furoate/umeclidinium/vilanterolGlaxoSmithKlineAsthmaPhase 3NCT05757102
2027-01-28Alpelisib (BYL719)NovartisHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT05038735
2027-01-29IptacopanNovartisC3GPhase 3NCT04817618
2027-01-29Pembrolizumab, Disitamab VedotinMerck & Co., Pfizer, RemeGen Co., Ltd.Urothelial CarcinomaPhase 3NCT05911295
2027-01-29ZiltivekimabNovo NordiskCardiovascular Risk, Acute Myocardial Infarction (AMI)Phase 3NCT06118281
2027-01-30Tamoxifen (Soltamox), Anastrozole, Letrozole, ExemestaneMayne Pharma, Rosemont Pharmaceuticals, ANI Pharmaceuticals, Inc.HR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT04906395
2027-01-30afimkibartPfizer, RocheUlcerative ColitisPhase 3NCT06589986
2027-01-31RituximabBiogen, Chugai Pharma, RocheMantle Cell LymphomaPhase 3NCT03267433
2027-01-31PembrolizumabMerck & Co.Urinary Bladder NeoplasmsPhase 3NCT04241185
2027-01-31TicagrelorAstraZenecaIntracranial Arteriosclerosis, StrokePhase 3NCT05047172
2027-01-31Macitentan, TadalafilJohnson & Johnson, Eli Lilly, Nippon ShinyakuHypertension, PulmonaryPhase 3NCT05179876
2027-01-31CenobamateAngelini Pharma S.p.A. (A.C.R.A.F. S.p.A.), Eurofarma Laboratorios, Hikma Pharmaceuticals PLCEpilepsyPhase 3NCT06579573
2027-01-31VenetoclaxAbbVie, RocheAcute T Lymphoblastic Leukemia (T-ALL)Phase 3NCT07541755
2027-01-31RemimazolamJiangsu Hengrui PharmaceuticalsRemimazolam Besylate, Mechanically Ventilated ICU Patients, SedationPhase 3NCT07596589

February 2027

Primary completionDrugDeveloperIndicationPhaseStudy
2027-02 (month only)BosentanJohnson & JohnsonIschemic Optic NeuropathyPhase 3NCT02377271
2027-02 (month only)metforminObesity, Childhood, Insulin ResistancePhase 3NCT04578652
2027-02 (month only)Venetoclax, Azacitidine, Gemtuzumab OzogamicinAbbVie, Roche, Bristol-Myers SquibbAcute Myeloid LeukemiaPhase 3NCT05183035
2027-02 (month only)CarisbamateSK Biopharmaceuticals Co., Ltd.EpilepsyPhase 3NCT05219617
2027-02 (month only)Pembrolizumab, Sacituzumab GovitecanMerck & Co., Gilead SciencesBreast CancerPhase 3NCT05382286
2027-02 (month only)CT-P53CelltrionMultiple SclerosisPhase 3NCT05906992
2027-02 (month only)orforglipronChugai Pharma, Eli LillyObesityPhase 3NCT06672549
2027-02 (month only)CT-P51CelltrionNon-Small Cell Lung CancerPhase 3NCT06939595
2027-02 (month only)Tabirafusp alfaKodiak Sciences Inc.Macular Edema Secondary to InflammationPhase 3NCT06996080
2027-02 (month only)ribupatideJiangsu Hengrui Pharmaceuticals, Kailera TherapeuticsType 2 DiabetesPhase 3NCT07060456
2027-02 (month only)stapokibartAeira Pte. Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Keymed BiosciencesAtopic DermatitisPhase 3NCT07106372
2027-02 (month only)difamilastAcrotech Biopharma, Otsuka HoldingsAtopic DermatitisPhase 3NCT07184645
2027-02 (month only)TQC3721AstraZeneca, Sino BiopharmaceuticalChronic Obstructive Pulmonary DiseasePhase 3NCT07464587
2027-02 (month only)ElismetrepTriGemX BioMigrainePhase 3NCT07645924
2027-02-01LetrozoleNovartisLow Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8, Stage III Fallopian Tube Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Primary Peritoneal Cancer AJCC v8, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8Phase 3NCT04095364
2027-02-01Apatinib, FulvestrantAdvenchen Laboratories, Elevar Therapeutics, Inc., HLB Life ScienceHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT06447623
2027-02-01Montelukast (Singulair)OrganonMyocardial Infarction (MI)Phase 3NCT07320625
2027-02-01ModafinilApotex Inc.Inflammatory Bowel Disease (Crohn&#39Phase 2/3NCT07582458
2027-02-02valproate, HaloperidolAbbVie, Sanofi, Johnson & JohnsonDelirium, Epileptics, NeurolepticsPhase 2/3NCT05431595
2027-02-03LevosimendanOrion Corporation, Tenax TherapeuticsCardiogenic ShockPhase 3NCT04020263
2027-02-10guselkumabJohnson & JohnsonUlcerative ColitisPhase 3NCT06260163
2027-02-10icotrokinraJohnson & Johnson, Protagonist TherapeuticsPsoriatic ArthritisPhase 3NCT06807424
2027-02-10teduglutide (Gattex)Takeda Pharmaceutical CompanyShort Bowel SyndromePhase 3NCT06973304
2027-02-14Tirzepatide (Zepbound)Eli LillyObesityPhase 3NCT07481747
2027-02-15AcalabrutinibAstraZenecaLymphoma, Mantle CellPhase 3NCT02972840
2027-02-16RepotrectinibBristol-Myers Squibb, Zai LabNon-Small Cell Lung Cancer, ROS1-Positive Non-Small Cell Lung CancerPhase 3NCT06140836
2027-02-16HDM1002Hangzhou Zhongmei Huadong PharmaceuticalType 2 DiabetesPhase 3NCT07082114
2027-02-18Zibotentan + DapagliflozinAstraZenecaChronic Kidney DiseasePhase 3NCT06087835
2027-02-20CapecitabineCheplapharm Arzneimittel GmbHNasopharyngeal CarcinomaPhase 3NCT06239727
2027-02-20CenvacibartRegeneron PharmaceuticalsVenous ThromboembolismPhase 3NCT07015905
2027-02-20AND017Kind PharmaceuticalsChronic Kidney DiseasePhase 3NCT07494409
2027-02-22AcalabrutinibAstraZenecaDiffuse Large B-Cell LymphomaPhase 3NCT04529772
2027-02-22OsimertinibAstraZenecaCancerPhase 3NCT05629234
2027-02-22LaroprovstatAstraZenecaAtherosclerotic Cardiovascular DiseasePhase 2/3NCT06834932
2027-02-22remibrutinibNovartisChronic Spontaneous UrticariaPhase 3NCT06868212
2027-02-23AnifrolumabAstraZeneca, MedImmune LLCSystemic Lupus ErythematosusPhase 3NCT05138133
2027-02-23SuzetrigineVertex PharmaceuticalsTotal Knee Replacement Surgery, Post-operative PainPhase 3NCT07548385
2027-02-24IncobotulinumtoxinA (Xeomin)Merz PharmaceuticalsMigrainePhase 3NCT05598723
2027-02-25AbemaciclibEli LillyBreast CancerPhase 3NCT06341621
2027-02-26EverolimusNovartisEpilepsyPhase 3NCT02962414
2027-02-26Alpelisib (BYL719)NovartisBreast CancerPhase 3NCT04208178
2027-02-26Tenapanor (Ibsrela)Ardelyx, Knight TherapeuticsChronic Idiopathic Constipation (CIC)Phase 3NCT07382167
2027-02-28metforminIntermittent ClaudicationPhase 3NCT05132439
2027-02-28MevrometostatPfizerMetastatic Castrate Resistant Prostate Cancer (mCRPC)Phase 3NCT06551324

March 2027

Primary completionDrugDeveloperIndicationPhaseStudy
2027-03 (month only)EpirubicinPfizerBreast CancerPhase 3NCT02455141
2027-03 (month only)RituximabBiogen, Chugai Pharma, RocheSevere Forms of Mucous Membrane PemphigoidPhase 3NCT03295383
2027-03 (month only)AnakinraSwedish Orphan Biovitrum AB (publ)Kawasaki DiseasePhase 3NCT04656184
2027-03 (month only)Cariprazine (Vraylar)AbbVie, Gedeon Richter, Tanabe Pharma CorporationBipolar DisorderPhase 3NCT04777357
2027-03 (month only)baricitinibEli Lilly, IncyteRheumatoid ArthritisPhase 3NCT04870203
2027-03 (month only)ResmetiromMadrigal PharmaceuticalsMASH / NASHPhase 3NCT04951219
2027-03 (month only)Atezolizumab, Bevacizumab, IpilimumabChugai Pharma, Roche, Bristol-Myers SquibbColorectal Cancer, Metastatic Colorectal Cancer, Advanced Metastatic Colorectal CancerPhase 2/3NCT05141721
2027-03 (month only)OlezarsenIonis Pharmaceuticals, Swedish Orphan Biovitrum AB (publ), TheratechnologiesSevere Hypertriglyceridemia, HypertriglyceridemiaPhase 3NCT05681351
2027-03 (month only)upadacitinibAbbVieSystemic Lupus ErythematosusPhase 3NCT05843643
2027-03 (month only)risankizumabAbbVie, Boehringer IngelheimCrohn's DiseasePhase 3NCT06063967
2027-03 (month only)TelitaciceptRemeGen Co., Ltd., Vor BioGeneralized Myasthenia GravisPhase 3NCT06456580
2027-03 (month only)ZorevunersenBiogen, Stoke Therapeutics, Inc.Dravet SyndromePhase 3NCT06872125
2027-03 (month only)QLM3003Qilu PharmaceuticalAtopic DermatitisPhase 3NCT06880276
2027-03 (month only)Rituximab, SHR-A1912Biogen, Chugai Pharma, RocheDiffuse Large B-Cell LymphomaPhase 3NCT06929624
2027-03 (month only)IncobotulinumtoxinA (Xeomin)Merz PharmaceuticalsMigrainePhase 3NCT07018700
2027-03 (month only)IncobotulinumtoxinA (Xeomin)Merz PharmaceuticalsMigrainePhase 3NCT07018713
2027-03 (month only)TQC3721AstraZeneca, Sino BiopharmaceuticalChronic Obstructive Pulmonary DiseasePhase 3NCT07147946
2027-03 (month only)Axitinib intravitreal implant (OTX-TKI)OCULAR THERAPEUTIX, INCNon-Proliferative Diabetic RetinopathyPhase 3NCT07235085
2027-03 (month only)RezvilutamideJiangsu Hengrui PharmaceuticalsProstate CancerPhase 3NCT07241416
2027-03 (month only)ribupatideJiangsu Hengrui Pharmaceuticals, Kailera TherapeuticsObesityPhase 3NCT07285902
2027-03 (month only)SHR-1918Jiangsu Hengrui PharmaceuticalsHypertriglyceridemiaPhase 3NCT07349615
2027-03 (month only)Arsenic trioxide (QTX-2101)Quetzal TherapeuticsAcute Myeloid LeukemiaPhase 3NCT07504458
2027-03-01Rituximab, Azacitidine (Onureg)Biogen, Chugai Pharma, RocheDiffuse Large B-Cell Lymphoma, Follicular LymphomaPhase 2/3NCT04799275
2027-03-01Utidelone, CapecitabineBeijing Biostar Pharmaceuticals, Cheplapharm Arzneimittel GmbHHR+/HER2- Metastatic Breast CancerPhase 3NCT05172518
2027-03-01RecaticimabJiangsu Hengrui PharmaceuticalsStrokePhase 3NCT07002476
2027-03-01cagrilintide/semaglutideNovo NordiskObesityPhase 3NCT07011667
2027-03-01AND017Kind PharmaceuticalsChronic Kidney DiseasePhase 3NCT07487727
2027-03-01DepemokimabGlaxoSmithKlineAsthmaPhase 3NCT07671001
2027-03-01GabapentinPfizer, ViatrisPostdural Puncture Headache (PDPH)Phase 2/3NCT07916116
2027-03-08Daratumumab, CT-P44Johnson & Johnson, CelltrionMultiple MyelomaPhase 3NCT06952478
2027-03-09bimekizumabUCBPsoriatic Arthritis, PsoriasisPhase 3NCT06506916
2027-03-11Nivolumab, IpilimumabBristol-Myers Squibb, Ono PharmaceuticalRenal Cell CarcinomaPhase 3NCT03873402
2027-03-13setmelanotideRhythm PharmaceuticalsObesity, Hypothalamic ObesityPhase 3NCT06760546
2027-03-15RucaparibpharmaandProstate CancerPhase 3NCT04455750
2027-03-16Apadamtase alfaTakeda Pharmaceutical CompanyThrombotic Thrombocytopenic Purpura (TTP)Phase 3NCT04683003
2027-03-16EmpagliflozinBoehringer Ingelheim, Eli LillyCardiogenic ShockPhase 3NCT05879276
2027-03-17tofacitinibPfizerUlcerative ColitisPhase 3NCT04624230
2027-03-18RituximabBiogen, Chugai Pharma, RocheMarginal Zone LymphomaPhase 3NCT04212013
2027-03-20Olanzapine (Zyprexa)Cheplapharm Arzneimittel GmbH, Eli LillyAdvanced Cancer, Olanzapine, Progression Free SurvivalPhase 3NCT06338683
2027-03-20Roflumilast (Daliresp)AstraZenecaDepressive Disorder, MajorPhase 3NCT06860958
2027-03-20VildagliptinCipla, Novartis, Sumitomo PharmaPoly Cystic Ovary SyndromePhase 2/3NCT07811011
2027-03-22Cemiplimab, FianlimabRegeneron PharmaceuticalsMelanomaPhase 3NCT06246916
2027-03-23ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceHR+/HER2- Breast CancerPhase 3NCT06977893
2027-03-25guselkumabJohnson & JohnsonCrohn's DiseasePhase 3NCT05347095
2027-03-25FitusiranAlnylam Pharmaceuticals, SanofiHemophiliaPhase 3NCT05662319
2027-03-26Eptinezumab (Vyepti)H. LundbeckMigrainePhase 3NCT04965675
2027-03-26VAY736NovartisSystemic Lupus ErythematosusPhase 3NCT05639114
2027-03-26Osimertinib, BecotatugAstraZeneca, Shanghai JMT-BioNon-Small Cell Lung CancerPhase 3NCT06380348
2027-03-28PertuzumabRocheSolid TumorsPhase 3NCT02320435
2027-03-29Staccato AlprazolamNova Pneuma Inc., UCBEpilepsyPhase 3NCT05077904
2027-03-30Sacituzumab Govitecan, CapecitabineGilead Sciences, Cheplapharm Arzneimittel GmbHHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT04595565
2027-03-30Ferric derisomaltoseChina Medical System, Nippon Shinyaku, PfizerIron Deficiency AnemiaPhase 3NCT05462704
2027-03-30olatorepatideHansoh Pharmaceutical Group, Regeneron PharmaceuticalsType 2 DiabetesPhase 3NCT07156500
2027-03-30olatorepatideHansoh Pharmaceutical Group, Regeneron PharmaceuticalsType 2 DiabetesPhase 3NCT07156539
2027-03-31Nivolumab, IpilimumabBristol-Myers Squibb, Ono PharmaceuticalNon-Small Cell Lung CancerPhase 3NCT03391869
2027-03-31GemcitabineEli LillyChildhood Hepatocellular Carcinoma, Childhood Malignant Liver Neoplasm, Fibrolamellar Carcinoma, Hepatoblastoma, Hepatocellular Malignant Neoplasm, Not Otherwise SpecifiedPhase 3NCT03533582
2027-03-31NivolumabBristol-Myers Squibb, Ono PharmaceuticalAnal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Metastatic Anal Squamous Cell Carcinoma, Recurrent Anal Squamous Cell Carcinoma, Stage III Anal Cancer AJCC v8, Stage IV Anal Cancer AJCC v8, Unresectable Anal Squamous Cell CarcinomaPhase 3NCT04444921
2027-03-31AtezolizumabChugai Pharma, RocheBreast CancerPhase 3NCT04873362
2027-03-31ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceGastric or Esophagogastric Junction AdenocarcinomaPhase 3NCT05180734
2027-03-31Binimetinib, EncorafenibOno Pharmaceutical, Pfizer, Pierre Fabre MedicamentMelanomaPhase 3NCT05270044
2027-03-31RegorafenibBayerColorectal CancerPhase 3NCT05794971
2027-03-31PF-06651600PfizerVitiligoPhase 3NCT06163326
2027-03-31Liraglutide (Victoza)Novo NordiskDelirium, PostoperativePhase 3NCT06361238
2027-03-31Pomalidomide, Sanritatug, DexamethasoneBristol-Myers Squibb, Hangzhou Sumgen Biotech Co., Ltd.Multiple MyelomaPhase 3NCT06508983
2027-03-31OlverembatinibAscentage Pharma Group Inc., Innovent BiologicsGISTPhase 3NCT06640361
2027-03-31HS-20137Hansoh Pharmaceutical Group, Qyuns TherapeuticsPsoriasisPhase 3NCT06844799
2027-03-31IFx-2.0TuHURA BiosciencesMerkel Cell CarcinomaPhase 2/3NCT06947928
2027-03-31metforminObesity and Cardiovascular Risk, Insulin Resistance, Obesity (Body Mass Index &gtPhase 3NCT07297290
2027-03-31NeovasculgenArtgen BiotechUlcer Foot, Mellitus DiabetesPhase 3NCT07391319
2027-03-31SuzetrigineVertex PharmaceuticalsOpioid Consumption, Postoperative, Multimodal Analgesia, Ureteroscopy, Ureteral Stents, Ureteral Stent-Related SymptomsPhase 3NCT07654296

April 2027

Primary completionDrugDeveloperIndicationPhaseStudy
2027-04 (month only)N-acetylcysteineApotex Inc., Phebra Pty LtdThoracic Surgery, Atrial Fibrillation in High Risk PatientsPhase 3NCT02750319
2027-04 (month only)Zoledronic acidNovartisGiant Cell Tumor of BonePhase 3NCT03295981
2027-04 (month only)IbudilastMediciNova, Inc.Amyotrophic Lateral SclerosisPhase 2/3NCT04057898
2027-04 (month only)Clemizole (EPX-100)Harmony BiosciencesEpilepsy, Dravet SyndromePhase 3NCT04462770
2027-04 (month only)DocetaxelSanofiHR+/HER2- Metastatic Breast CancerPhase 3NCT04540692
2027-04 (month only)DapagliflozinAstraZeneca, Ono PharmaceuticalDiabetes Mellitus, Atrial FibrillationPhase 3NCT05174052
2027-04 (month only)Bevacizumab, Mirvetuximab soravtansineRoche, AbbVie, Takeda Pharmaceutical CompanyOvarian CancerPhase 3NCT05445778
2027-04 (month only)RituximabBiogen, Chugai Pharma, RocheAcute Demyelinating Syndrome, Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseasePhase 3NCT05545384
2027-04 (month only)Bortezomib, Lenalidomide, Isatuximab, Iberdomide, DexamethasoneJanssen, Takeda Pharmaceutical Company, Bristol-Myers SquibbMultiple MyelomaPhase 3NCT05558319
2027-04 (month only)AzetukalnerXenon PharmaceuticalsEpilepsy, Primary Generalized Tonic-Clonic SeizuresPhase 3NCT05667142
2027-04 (month only)AbemaciclibEli LillyHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT05696626
2027-04 (month only)Sacituzumab TirumotecanMerck & Co., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Breast CancerPhase 3NCT06279364
2027-04 (month only)Cannabidiol (Epidiolex)GW Pharmaceuticals, Jazz PharmaceuticalsSanfilippo Syndrome, Mucopolysaccharidosis IIIPhase 2/3NCT06333041
2027-04 (month only)cadisegliatinG42 Healthcare, vTv TherapeuticsType 1 DiabetesPhase 3NCT06334133
2027-04 (month only)Pitolisant (Wakix)Bioprojet, Harmony Biosciences, ViatrisPrader-Willi SyndromePhase 3NCT06366464
2027-04 (month only)Futibatinib (Lytgobi), FulvestrantTaiho Pharmaceutical, AstraZenecaAdvanced/Metastatic CancerPhase 2/3NCT06506955
2027-04 (month only)Sacubitril/valsartanNovartis, Otsuka HoldingsHeart FailurePhase 3NCT06712030
2027-04 (month only)tocilizumabChugai Pharma, RocheSickle Cell Disease, Acute Chest SyndromePhase 3NCT06818266
2027-04 (month only)Tabirafusp alfaKodiak Sciences Inc.Macular Edema Secondary to InflammationPhase 3NCT06990399
2027-04 (month only)NivolumabBristol-Myers Squibb, Ono PharmaceuticalMelanomaPhase 3NCT07221734
2027-04 (month only)GS101Jiangsu Genscend BiopharmaceuticalAtopic DermatitisPhase 3NCT07386743
2027-04 (month only)RosuvastatinAstraZeneca, ShionogiPeripheral Nerve DiseasePhase 2/3NCT07504198
2027-04 (month only)VadadustatAkebia Therapeutics, Medice, Tanabe Pharma CorporationChronic Kidney DiseasePhase 3NCT07565701
2027-04-01Anastrozole, FulvestrantANI Pharmaceuticals, Inc., AstraZeneca, Laboratoires Juvisé PharmaceuticalsBreast CancerPhase 3NCT01953588
2027-04-01DocetaxelSanofiProstate CancerPhase 3NCT03574571
2027-04-01Bevacizumab, TemozolomideRoche, Merck & Co.Glioblastoma, GliomaPhase 3NCT05271240
2027-04-01N-acetylcysteineApotex Inc., Phebra Pty LtdFeeding Delays, Neonates and Term InfantsPhase 2/3NCT07049952
2027-04-01NaltrexoneAlcohol Use Disorder (AUD)Phase 3NCT07433413
2027-04-01VenetoclaxAbbVie, RocheAcute Myeloid LeukemiaPhase 2/3NCT07537257
2027-04-05Bortezomib, Lenalidomide, Isatuximab, DexamethasoneJanssen, Takeda Pharmaceutical Company, Bristol-Myers SquibbMultiple MyelomaPhase 3NCT03319667
2027-04-05LumateperoneIntra-Cellular Therapies, Johnson & JohnsonMajor Depressive DisorderPhase 3NCT05850689
2027-04-06OlaparibAstraZeneca, Merck & Co.HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer, Breast CancerPhase 3NCT04421963
2027-04-06Elexacaftor / tezacaftor / ivacaftorVertex PharmaceuticalsCystic FibrosisPhase 3NCT05331183
2027-04-06SuzetrigineVertex PharmaceuticalsDiabetic Peripheral Neuropathic PainPhase 3NCT07231419
2027-04-08DexamethasonePrimary Immune Thrombocytopenia (ITP)Phase 3NCT07559331
2027-04-10FinerenoneBayerChronic Kidney DiseasePhase 3NCT05196035
2027-04-12VAY736NovartisSystemic Lupus ErythematosusPhase 3NCT05624749
2027-04-15TislelizumabBeOne MedicinesBladder CancerPhase 3NCT06364904
2027-04-15NaltrexoneOverdose AccidentalPhase 2/3NCT06633900
2027-04-15Nerandomilast (Jascayd)Boehringer IngelheimInterstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung DiseasesPhase 3NCT06806592
2027-04-16Dapagliflozin, BalcinrenoneAstraZeneca, Ono PharmaceuticalHeart FailurePhase 3NCT06307652
2027-04-16EmpagliflozinBoehringer Ingelheim, Eli LillyChronic Kidney DiseasePhase 3NCT07107945
2027-04-16RituximabBiogen, Chugai Pharma, RocheANCA Associated Vasculitis (AAV)Phase 3NCT07168161
2027-04-17Enasidenib, IvosidenibBristol-Myers Squibb, ServierAcute Myeloid LeukemiaPhase 3NCT03839771
2027-04-18SaroglitazarZydus LifesciencesPrimary Biliary CholangitisPhase 3NCT06427395
2027-04-19ABP 692AmgenMultiple SclerosisPhase 3NCT06700343
2027-04-20CamizestrantAstraZenecaBreast CancerPhase 3NCT05774951
2027-04-20tocilizumabChugai Pharma, RocheIschemic StrokePhase 3NCT07509645
2027-04-25DocetaxelSanofiGastric CancerPhase 2/3NCT06028737
2027-04-25lebrikizumabAlmirall, Eli LillyAtopic DermatitisPhase 3NCT06526182
2027-04-25ORMD-0801Lifeward Ltd.Type 2 DiabetesPhase 3NCT06731075
2027-04-27maridebart cafraglutideAmgenObesityPhase 3NCT06987695
2027-04-28Nerandomilast (Jascayd)Boehringer IngelheimIdiopathic Pulmonary FibrosisPhase 3NCT06238622
2027-04-28SYHX1901CSPC Ouyi Pharmaceutical Co., CSPC Pharmaceutical GroupPsoriasisPhase 3NCT06943950
2027-04-30Venetoclax, Obinutuzumab, AcalabrutinibAbbVie, Roche, AstraZenecaChronic Lymphocytic LeukemiaPhase 3NCT03836261
2027-04-30Ferric derisomaltoseChina Medical System, Nippon Shinyaku, PfizerIron Deficiency AnemiaPhase 3NCT05179226
2027-04-30Semaglutide (Ozempic), AnastrozoleNovo Nordisk, ANI Pharmaceuticals, Inc., AstraZenecaKlinefelter SyndromePhase 3NCT05586802
2027-04-30Nab-paclitaxel, Pembrolizumab, DocetaxelBristol-Myers Squibb, Merck & Co., SanofiHead and Neck Squamous Cell CarcinomaPhase 3NCT06102395
2027-04-30IptacopanNovartisGeneralized Myasthenia GravisPhase 3NCT06517758
2027-04-30Ruxolitinib (Opzelura)Incyte, MaruhoVitiligoPhase 3NCT06804811
2027-04-30LuvometinibShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.GliomaPhase 3NCT07004075
2027-04-30EmpagliflozinBoehringer Ingelheim, Eli LillyHeart FailurePhase 3NCT07038356
2027-04-30BGM0504BrightGene Bio-Medical Technology, China Resources Sanjiu Medical & PharmaceuticalType 2 DiabetesPhase 3NCT07064486
2027-04-30N-acetylcysteineApotex Inc., Phebra Pty LtdKidney Function Issue, Acute Kidney Injury, Cancer (Solid Tumors), Kidney Function Tests, Acetylcysteine Adverse ReactionPhase 2/3NCT07156786
2027-04-30TVAX-008Grand Theravac Life Science (Nanjing) Co., Ltd.Chronic Hepatitis BPhase 3NCT07282249
2027-04-30BAT5906Bio-Thera SolutionsDiabetic Macular Edema (DME)Phase 3NCT07515079
2027-04-30DapagliflozinAstraZeneca, Ono PharmaceuticalPoly Cystic Ovary SyndromePhase 2/3NCT07810998

May 2027

Primary completionDrugDeveloperIndicationPhaseStudy
2027-05 (month only)Lovotibeglogene autotemcel (Lyfgenia)Genetix Biotherapeutics Inc. (formerly bluebird bio, Inc.), SPIMACOSickle Cell DiseasePhase 3NCT04293185
2027-05 (month only)Ubrogepant (Ubrelvy)AbbVieMigrainePhase 3NCT05125302
2027-05 (month only)mocravimodPriothera SASAcute Myeloid LeukemiaPhase 3NCT05429632
2027-05 (month only)RituximabBiogen, Chugai Pharma, RocheMultiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Demyelinating Autoimmune Diseases, CNS, Autoimmune Diseases of the Nervous System, Nervous System Diseases, Demyelinating DiseasesPhase 3NCT05834855
2027-05 (month only)FampridineMerz TherapeuticsMultiple SclerosisPhase 3NCT06136728
2027-05 (month only)DexamethasoneRheumatic Fever, Sydenham ChoreaPhase 3NCT06259006
2027-05 (month only)lebrikizumabAlmirall, Eli LillyChronic Rhinosinusitis With Nasal Polyps (CRSwNP)Phase 3NCT06338995
2027-05 (month only)PumitamigBioNTech, Bristol-Myers SquibbSmall Cell Lung CancerPhase 3NCT06616532
2027-05 (month only)upadacitinibAbbVieUlcerative ColitisPhase 3NCT06660693
2027-05 (month only)Sacituzumab TirumotecanMerck & Co., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Non-Small Cell Lung CancerPhase 3NCT06670196
2027-05 (month only)Trastuzumab rezetecanGlenmark Pharmaceuticals Ltd., Jiangsu Hengrui PharmaceuticalsOvarian CancerPhase 3NCT06828354
2027-05 (month only)QL2108Qilu PharmaceuticalAtopic DermatitisPhase 3NCT06884891
2027-05 (month only)onabotulinumtoxinAAbbVieBase-of-thumb Osteoarthritis, OsteoarthritisPhase 2/3NCT06902805
2027-05 (month only)IvonescimabAkeso, Summit TherapeuticsNon-Small Cell Lung CancerPhase 3NCT06928389
2027-05 (month only)Trastuzumab brengitecanSichuan Baili PharmaceuticalHER2-low Breast CancerPhase 3NCT06957886
2027-05 (month only)AzetukalnerXenon PharmaceuticalsMajor Depressive DisorderPhase 3NCT07076407
2027-05 (month only)AlixorextonAlkermes plcNarcolepsyPhase 3NCT07455383
2027-05 (month only)AlixorextonAlkermes plcNarcolepsyPhase 3NCT07502443
2027-05 (month only)orforglipronChugai Pharma, Eli LillyType 2 DiabetesPhase 3NCT07613307
2027-05-01EmpagliflozinBoehringer Ingelheim, Eli LillyChronic Kidney DiseasePhase 3NCT05715814
2027-05-01CamrelizumabElevar Therapeutics, Inc., Jiangsu Hengrui PharmaceuticalsHepatocellular CarcinomaPhase 3NCT05738616
2027-05-01Dapagliflozin, FinerenoneAstraZeneca, Ono Pharmaceutical, BayerType 2 Diabetes, Chronic Kidney DiseasePhase 3NCT07598864
2027-05-02abrocitinibPfizerEczemaPhase 3NCT06807268
2027-05-03Trastuzumab Deruxtecan, PertuzumabAstraZeneca, Daiichi Sankyo, RocheBreast CancerPhase 3NCT04784715
2027-05-03InavolisibRocheBreast CancerPhase 3NCT05894239
2027-05-05Pembrolizumab, Olaparib, pemetrexedMerck & Co., AstraZeneca, Eli LillyNon-Small Cell Lung CancerPhase 3NCT04380636
2027-05-06FrexalimabSanofiMultiple SclerosisPhase 3NCT06141473
2027-05-07mazdutideEli Lilly, Innovent BiologicsObesityPhase 3NCT06931028
2027-05-08Capsaicin (Qutenza)Apotex Inc., BCWorld Pharm, ClinectCoccyx Disorder, Neuropathic Pain, CoccygodyniaPhase 3NCT06023706
2027-05-10InclisiranAlnylam Pharmaceuticals, NovartisAtherosclerotic Cardiovascular DiseasePhase 3NCT05030428
2027-05-10Sacituzumab TirumotecanMerck & Co., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Non-Small Cell Lung CancerPhase 3NCT06074588
2027-05-11cagrilintideNovo NordiskObesityPhase 3NCT07220642
2027-05-12ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceResectable Locally Advanced Thoracic Esophageal Squamous Cell CarcinomaPhase 3NCT04848753
2027-05-12cagrilintideNovo NordiskObesity, Type 2 DiabetesPhase 3NCT07220759
2027-05-12RC148, CapecitabineAbbVie, RemeGen Co., Ltd., Cheplapharm Arzneimittel GmbHColorectal Cancer, Metastatic Colorectal CancerPhase 2/3NCT07462143
2027-05-14Nab-paclitaxel, Ivonescimab, LigufalimabBristol-Myers Squibb, Akeso, Summit TherapeuticsPancreatic CancerPhase 3NCT06953999
2027-05-15TislelizumabBeOne MedicinesNasopharyngeal CarcinomaPhase 3NCT06383780
2027-05-15Entecavir (Baraclude)Bristol-Myers SquibbChronic Hepatitis BPhase 3NCT06966232
2027-05-15TelikibartGenrix BioAllergic Rhinitis, SeasonalPhase 3NCT07199257
2027-05-17remibrutinibNovartisHidradenitis SuppurativaPhase 3NCT06799000
2027-05-17CenvacibartRegeneron PharmaceuticalsVenous ThromboembolismPhase 3NCT07213778
2027-05-18zasocitinibTakeda Pharmaceutical CompanyPsoriatic ArthritisPhase 3NCT06671483
2027-05-18zasocitinibTakeda Pharmaceutical CompanyPsoriatic ArthritisPhase 3NCT06671496
2027-05-18cagrilintideNovo NordiskObesityPhase 3NCT07745504
2027-05-19NemtabrutinibMerck & Co.Chronic Lymphocytic LeukemiaPhase 3NCT05624554
2027-05-20peginterferon beta-1aBiogenMultiple SclerosisPhase 3NCT03958877
2027-05-21FampridineMerz TherapeuticsSpinocerebellar Ataxia 27B (SCA27B)Phase 3NCT07185347
2027-05-27PembrolizumabMerck & Co.Endometrial NeoplasmsPhase 3NCT05173987
2027-05-27ZipalertinibCullinan Therapeutics Inc., Taiho PharmaceuticalNon-Small Cell Lung CancerPhase 3NCT05973773
2027-05-27CentanafadineOtsuka HoldingsAttention Deficit Hyperactivity DisorderPhase 3NCT07759154
2027-05-28Ravulizumab, EculizumabAstraZeneca, Alexion Pharmaceuticals, Inc. (subsidiary of AstraZeneca)Paroxysmal Nocturnal HemoglobinuriaPhase 3NCT06449001
2027-05-28Rosuvastatin, laroprovstat/rosuvastatinAstraZeneca, ShionogiAtherosclerotic Cardiovascular DiseasePhase 3NCT07619118
2027-05-29zovaglutideBeijing QL BiopharmaceuticalObesityPhase 3NCT07230119
2027-05-30zasocitinibTakeda Pharmaceutical CompanyPsoriasisPhase 3NCT07752108
2027-05-31NivolumabBristol-Myers Squibb, Ono PharmaceuticalNon-Small Cell Lung CancerPhase 3NCT02595944
2027-05-31PembrolizumabMerck & Co.Non-Small Cell Lung CancerPhase 3NCT05085028
2027-05-31ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceCholangiocarcinomaPhase 3NCT05342194
2027-05-31Zoledronic acidNovartisImaging Examination Shows at Least One Site With Bone Metastases From Soild TumorsPhase 3NCT06221072
2027-05-31SuzetrigineVertex PharmaceuticalsDiabetic Peripheral Neuropathic PainPhase 3NCT06628908
2027-05-31FelzartamabBiogenIgA NephropathyPhase 3NCT06935357
2027-05-31tanruprubartAnnexon, Inc.Guillain-Barré SyndromePhase 3NCT07020819
2027-05-31NeovasculgenArtgen BiotechIC, Interstitial Cystitis and Bladder Pain Syndrome, Interstitial Cystitis, ChronicPhase 2/3NCT07391306
2027-05-31IvabradineAmgen, ServierCardiogenic Shock Post Myocardial InfarctionPhase 3NCT07714746

June 2027

Primary completionDrugDeveloperIndicationPhaseStudy
2027-06 (month only)Methotrexate, Rituximab, DexamethasoneBiogen, Chugai Pharma, RocheMature B-cell Non-Hodgkin LymphomaPhase 3NCT03206671
2027-06 (month only)Niraparib, DostarlimabGlaxoSmithKline, Zai LabOvarian Carcinosarcoma, Endometrial CarcinosarcomaPhase 2/3NCT03651206
2027-06 (month only)TemozolomideMerck & Co.GlioblastomaPhase 3NCT03663725
2027-06 (month only)VyxeosHandok, Jazz Pharmaceuticals, Nippon ShinyakuAcute Myeloid LeukemiaPhase 3NCT03897127
2027-06 (month only)PyrotinibDr. Reddy's Laboratories, HLB Life Science, Jiangsu Hengrui PharmaceuticalsBreast CancerPhase 3NCT03980054
2027-06 (month only)OlezarsenIonis Pharmaceuticals, Swedish Orphan Biovitrum AB (publ), TheratechnologiesFamilial Chylomicronemia SyndromePhase 3NCT05185843
2027-06 (month only)TovorafenibDay One Biopharmaceuticals, Inc., IpsenGliomaPhase 3NCT05566795
2027-06 (month only)Rituximab, EpcoritamabBiogen, Chugai Pharma, RocheDiffuse Large B-Cell Lymphoma, Large B-Cell LymphomaPhase 3NCT05578976
2027-06 (month only)Binimetinib, Niraparib, Zanidatamab, Encorafenib, Neratinib, Futibatinib (Lytgobi), IvosidenibOno Pharmaceutical, Pfizer, Pierre Fabre MedicamentBiliary Tract NeoplasmsPhase 3NCT05615818
2027-06 (month only)Pembrolizumab, Sacituzumab GovitecanMerck & Co., Gilead SciencesBreast CancerPhase 3NCT05633654
2027-06 (month only)Human Acellular Vessel (Humacyte)HumacyteEnd Stage Renal Disease (ESRD)Phase 3NCT05908084
2027-06 (month only)EnavogliflozinArcera Life Sciences, Daewoong PharmaceuticalTricuspid Regurgitation, Heart Failure With Preserved Ejection FractionPhase 3NCT06027307
2027-06 (month only)Tividenofusp alfaDenali TherapeuticsMucopolysaccharidosis Type IIPhase 2/3NCT06075537
2027-06 (month only)DapagliflozinAstraZeneca, Ono PharmaceuticalST Elevation Myocardial Infarction, Myocardial InfarctionPhase 3NCT06174753
2027-06 (month only)DexamethasoneLassa FeverPhase 2/3NCT06212336
2027-06 (month only)VoclosporinAurinia Pharmaceuticals, Otsuka HoldingsSystemic Lupus Erythematosus, Lupus NephritisPhase 3NCT06406205
2027-06 (month only)molgramostimSavara Inc.Autoimmune Pulmonary Alveolar ProteinosisPhase 3NCT06431776
2027-06 (month only)Izalontamab brengitecanBristol-Myers Squibb, Sichuan Baili PharmaceuticalUrothelial CarcinomaPhase 3NCT06857175
2027-06 (month only)Izalontamab brengitecanBristol-Myers Squibb, Sichuan Baili PharmaceuticalOvarian CancerPhase 3NCT06994195
2027-06 (month only)palopegteriparatideAscendis Pharma A/S, Pendopharm, TeijinHypoparathyroidismPhase 3NCT07081997
2027-06 (month only)Trastuzumab brengitecanSichuan Baili PharmaceuticalGastric Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaPhase 3NCT07152405
2027-06 (month only)retatrutideEli LillyObesityPhase 3NCT07232719
2027-06 (month only)GFH375GenFleet Therapeutics, Verastem, Inc.Metastatic Pancreatic CancerPhase 3NCT07262567
2027-06 (month only)MDR-001MindRank AIObesityPhase 3NCT07274137
2027-06 (month only)Arsenic trioxide (SDK001)SDK TherapeuticsAcute Myeloid LeukemiaPhase 3NCT07296445
2027-06 (month only)LB-102 (methylated amisulpride)LB PharmaceuticalsSchizophreniaPhase 3NCT07363577
2027-06 (month only)AlixorextonAlkermes plcNarcolepsyPhase 3NCT07540897
2027-06 (month only)filgotinibAlfasigma, Gilead SciencesPolyarticular Course Juvenile Idiopathic ArthritisPhase 3NCT07554495
2027-06-01Atezolizumab, BevacizumabChugai Pharma, RocheColorectal CancerPhase 3NCT02997228
2027-06-01adalimumabAbbVieNon-Infectious UveitisPhase 3NCT06258915
2027-06-01MethylprednisolonePfizerErythema MultiformePhase 3NCT06266221
2027-06-01CapecitabineCheplapharm Arzneimittel GmbHGastric CancerPhase 3NCT06532006
2027-06-01Ruxolitinib (Jakafi)Incyte, NovartisHemophagocytic Lymphohistiocytosis (HLH)Phase 2/3NCT06951971
2027-06-01Bevacizumab, Iparomlimab and tuvonralimabRoche, Qilu PharmaceuticalOvarian Clear Cell CarcinomaPhase 3NCT07002346
2027-06-01PioglitazoneTakeda Pharmaceutical CompanyType1diabetesPhase 3NCT07056699
2027-06-01BecotatugShanghai JMT-BioColorectal CancerPhase 3NCT07134205
2027-06-01Abatacept, Ruxolitinib (Jakafi)Bristol-Myers Squibb, Incyte, NovartisGraft-versus-Host DiseasePhase 2/3NCT07366801
2027-06-01PregabalinHypera S.A. (Brainfarma Indústria Química e Farmacêutica S/A, wholly-owned subsidiary), Pfizer, ViatrisDiabetic Peripheral Neuropathic Pain, Diabetic Peripheral NeuropathyPhase 3NCT07712913
2027-06-02dupilumabRegeneron Pharmaceuticals, SanofiPruritusPhase 3NCT05263206
2027-06-03remibrutinibNovartisHidradenitis SuppurativaPhase 3NCT06840392
2027-06-06Exagamglogene autotemcel (Casgevy)CRISPR Therapeutics, Vertex PharmaceuticalsSickle Cell DiseasePhase 3NCT05329649
2027-06-07DeupsilocinHelus PharmaMajor Depressive DisorderPhase 3NCT06793397
2027-06-08vedolizumab, upadacitinibTakeda Pharmaceutical Company, AbbVieCrohn's DiseasePhase 3NCT06227910
2027-06-08guselkumabJohnson & JohnsonCrohn's DiseasePhase 3NCT06408935
2027-06-09Exagamglogene autotemcel (Casgevy)CRISPR Therapeutics, Vertex PharmaceuticalsSickle Cell DiseasePhase 3NCT05477563
2027-06-09cagrilintide/semaglutideNovo NordiskType 2 DiabetesPhase 3NCT07817251
2027-06-11HSK39004AirNexis Therapeutics, Haisco Pharmaceutical GroupChronic Obstructive Pulmonary DiseasePhase 3NCT07658339
2027-06-11Tirzepatide (Zepbound)Eli LillyObesityPhase 3NCT07738276
2027-06-16maridebart cafraglutideAmgenObesityPhase 3NCT07871409
2027-06-18mibavademabRegeneron PharmaceuticalsObesityPhase 3NCT07220772
2027-06-20DuloxetineEli LillyBiliary DiseasePhase 3NCT06860984
2027-06-21LumateperoneIntra-Cellular Therapies, Johnson & JohnsonIrritability Associated With Autism Spectrum DisorderPhase 3NCT06690398
2027-06-21LumateperoneIntra-Cellular Therapies, Johnson & JohnsonIrritability Associated With Autism Spectrum DisorderPhase 3NCT06706674
2027-06-25tezepelumab, albuterol / budesonideAmgen, AstraZenecaAsthmaPhase 3NCT06473779
2027-06-28Xanomeline/trospium chlorideBristol-Myers Squibb, Zai LabBipolar DisorderPhase 3NCT07140913
2027-06-30Atezolizumab, Bevacizumab, Alectinib, Cobimetinib, Divarasib, Entrectinib, pemetrexed, Vemurafenib, DocetaxelChugai Pharma, Roche, ExelixisNon-Small Cell Lung CancerPhase 2/3NCT03178552
2027-06-30TislelizumabBeOne MedicinesUrothelial CarcinomaPhase 3NCT03967977
2027-06-30EtelcalcetideAmgen, Ono PharmaceuticalSecondary HyperparathyroidismPhase 3NCT03969329
2027-06-30nitric oxideKeenova Therapeutics, Linde HealthcareAKI, CHD - Congenital Heart Disease, SurgeryPhase 3NCT04216927
2027-06-30DurvalumabAstraZenecaEsophageal Squamous Cell CarcinomaPhase 3NCT04550260
2027-06-30Nivolumab, RituximabBristol-Myers Squibb, Ono Pharmaceutical, BiogenPrimary Mediastinal Large B-Cell LymphomaPhase 3NCT04759586
2027-06-30Pembrolizumab, Nogapendekin alfa inbakicept (Anktiva)Merck & Co., ImmunityBioNon-Small Cell Lung CancerPhase 2/3NCT05096663
2027-06-30Atezolizumab, Bevacizumab, pemetrexedChugai Pharma, Roche, Eli LillyNeoplasmsPhase 3NCT05112965
2027-06-30ObinutuzumabRocheSteroid-Dependent Nephrotic Syndrome, Steroid-Sensitive Nephrotic SyndromePhase 2/3NCT05786768
2027-06-30astegolimabRocheChronic Obstructive Pulmonary DiseasePhase 3NCT05878769
2027-06-30SotorasibAmgenNon-Small Cell Lung CancerPhase 3NCT05920356
2027-06-30Trastuzumab rezetecanGlenmark Pharmaceuticals Ltd., Jiangsu Hengrui PharmaceuticalsGastric CancerPhase 3NCT06123494
2027-06-30Toripalimab, GemcitabineCoherus BioSciences, Inc., Shanghai Junshi Bioscience, Eli LillyNasopharyngeal CarcinomaPhase 3NCT06235203
2027-06-30maralixibatMirum Pharmaceuticals, Inc., Takeda Pharmaceutical CompanyConstipation Chronic Idiopathic, Cystic FibrosisPhase 2/3NCT06413368
2027-06-30OlverembatinibAscentage Pharma Group Inc., Innovent BiologicsChronic Myeloid LeukemiaPhase 3NCT06423911
2027-06-30TicagrelorAstraZenecaAcute Ischemic StrokePhase 3NCT06853535
2027-06-30TelitaciceptRemeGen Co., Ltd., Vor BioIgA NephropathyPhase 3NCT07052981
2027-06-30TAK-921Takeda Pharmaceutical CompanyPancreatic CancerPhase 3NCT07066098
2027-06-30TislelizumabBeOne MedicinesGastric CancerPhase 3NCT07068516
2027-06-30BofanglutideA. Menarini, Gan & Lee Pharmaceuticals, JW PharmaceuticalObesityPhase 3NCT07150975
2027-06-30MethylprednisolonePfizerAdenovirus Infections, HumanPhase 3NCT07152600
2027-06-30RemimazolamJiangsu Hengrui PharmaceuticalsCritical IllnessPhase 3NCT07155265
2027-06-30Eptinezumab (Vyepti)H. LundbeckPost Traumatic HeadachePhase 3NCT07191145
2027-06-30tenofovir alafenamide (Vemlidy)Gilead SciencesChronic Hepatitis BPhase 2/3NCT07203118
2027-06-30THRV-1268Thryv TherapeuticsLong QT Syndrome (LQTS) 2Phase 2/3NCT07277582
2027-06-30Nerandomilast (Jascayd)Boehringer IngelheimALS (Amyotrophic Lateral Sclerosis)Phase 2/3NCT07321860
2027-06-30HiCM-188 (allogeneic iPSC-cardiomyocytes)HELP TherapeuticsHeart FailurePhase 3NCT07496372
2027-06-30Bempedoic acidCSL Seqirus, Daiichi Sankyo, Esperion TherapeuticsAtherosclerotic Cardiovascular DiseasePhase 3NCT07623915
2027-06-30Roflumilast (Zoryve foam)Arcutis Biotherapeutics, Sato Pharmaceutical Co., Ltd.Seborrheic DermatitisPhase 3NCT07683806

July 2027

Primary completionDrugDeveloperIndicationPhaseStudy
2027-07 (month only)upadacitinibAbbVieUlcerative ColitisPhase 3NCT03006068
2027-07 (month only)FampridineMerz TherapeuticsNerve Injury, Prostate CancerPhase 2/3NCT03701581
2027-07 (month only)FosigotifatorAbbVie, Calico Life Sciences LLCAmyotrophic Lateral SclerosisPhase 2/3NCT04297683
2027-07 (month only)VenetoclaxAbbVie, RocheMyelodysplastic Syndrome (MDS)Phase 3NCT04401748
2027-07 (month only)Denosumab (Xgeva)Amgen, Daiichi SankyoHR+/HER2- Metastatic Breast CancerPhase 3NCT04711109
2027-07 (month only)Atezolizumab, BevacizumabChugai Pharma, RocheHepatocellular CarcinomaPhase 3NCT04803994
2027-07 (month only)Mitizodone phosphateSunshine Lake PharmaMajor Depressive DisorderPhase 2/3NCT04984512
2027-07 (month only)PertuzumabRocheEsophageal Cancer, Esophageal AdenocarcinomaPhase 3NCT05188313
2027-07 (month only)DapagliflozinAstraZeneca, Ono PharmaceuticalHeart Failure, Chronic Kidney DiseasePhase 3NCT05374291
2027-07 (month only)PegcetacoplanApellis Pharmaceuticals, Biogen, Swedish Orphan Biovitrum AB (publ)C3G, IC-MPGN, C3 Glomerulopathy, C3 Glomerulonephritis, Complement 3 Glomerulopathy, Complement 3 Glomerulopathy (C3G), Complement 3 Glomerulonephritis, Dense Deposit Disease, DDD, Membranoproliferative Glomerulonephritis, Membranoproliferative Glomerulonephritis (MPGN), Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)Phase 3NCT05809531
2027-07 (month only)rexlemestrocel-LGrünenthal GmbH, Mesoblast, Tasly Pharmaceutical GroupChronic Low Back PainPhase 3NCT06325566
2027-07 (month only)PumitamigBioNTech, Bristol-Myers SquibbTriple Negative Breast Cancer(TNBC)Phase 3NCT06419621
2027-07 (month only)Nexiguran ziclumeranRegeneron PharmaceuticalsNeuromuscular Disease, Neuromuscular Diseases (NMD), Neurodegenerative Disease, Neurodegenerative Disease, Hereditary, Neurodegenerative Diseases, Neuromuscular Diseases, Nerve Disorders, Nervous System Disease, Nervous System Diseases, Genetic Disease, Inborn, Amyloidosis, Familial, Amyloidosis, Hereditary, Amyloidosis, Polyneuropathies, Amyloid Neuropathies, Amyloid Neuropathies, Familial, Peripheral Nervous System Disease, Peripheral Nervous System Diseases, Metabolism, Inborn Errors, Metabolic DiseasesPhase 3NCT06672237
2027-07 (month only)OsavampatorNeurocrine Biosciences, Takeda Pharmaceutical CompanyMajor Depressive DisorderPhase 3NCT06786624
2027-07 (month only)HLX15Dr. Reddy's Laboratories, Shanghai Henlius BiotechMultiple MyelomaPhase 3NCT06895512
2027-07 (month only)OsavampatorNeurocrine Biosciences, Takeda Pharmaceutical CompanyMajor Depressive DisorderPhase 3NCT06911112
2027-07 (month only)OsavampatorNeurocrine Biosciences, Takeda Pharmaceutical CompanyMajor Depressive DisorderPhase 3NCT06963021
2027-07 (month only)Sacituzumab TirumotecanMerck & Co., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.HR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT07071337
2027-07 (month only)SerplulimabAbbott, Accord Healthcare, EisaiPDAC - Pancreatic Ductal AdenocarcinomaPhase 3NCT07336953
2027-07 (month only)SCTB14Sinocelltech Group Ltd.Non-Small Cell Lung CancerPhase 3NCT07362459
2027-07 (month only)SuzetrigineVertex PharmaceuticalsAnalgesic EfficacyPhase 3NCT07525219
2027-07 (month only)DapagliflozinAstraZeneca, Ono PharmaceuticalAscites HepaticPhase 2/3NCT07684326
2027-07-01XY0206Shijiazhuang Yiling Pharmaceutical Co. LtdAcute Myeloid LeukemiaPhase 3NCT05876832
2027-07-01VK2735Viking TherapeuticsObesity, Type 2 DiabetesPhase 3NCT07104383
2027-07-01VK2735Viking TherapeuticsObesityPhase 3NCT07104500
2027-07-02MK-1406Merck & Co.InfluenzaPhase 3NCT07159763
2027-07-06Eptinezumab (Vyepti)H. LundbeckMigrainePhase 3NCT05897320
2027-07-09RiliprubartSanofiChronic Inflammatory Demyelinating PolyneuropathyPhase 3NCT06290141
2027-07-09SintilimabInnovent BiologicsHepatocellular Carcinoma (HCC), Radiotherapy, Adjuvant, Immune Checkpoint Inhibitor, TACE, Narrow MarginPhase 3NCT07186621
2027-07-09DA-302168SChendu DIAO Pharmaceutical GroupObesityPhase 3NCT07629544
2027-07-10Venetoclax, RituximabAbbVie, Roche, BiogenMantle Cell Lymphoma (MCL)Phase 3NCT06496308
2027-07-10ManfidokimabAkesoAtopic DermatitisPhase 3NCT06767540
2027-07-11Pembrolizumab, Sacituzumab TirumotecanMerck & Co., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.HR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT06312176
2027-07-12Nomelcitinib (D-2570)InventisBioPsoriasisPhase 3NCT07326813
2027-07-14BomedemstatMerck & Co.Essential ThrombocythemiaPhase 3NCT06079879
2027-07-15Venetoclax, Obinutuzumab, AcalabrutinibAbbVie, Roche, AstraZenecaChronic Lymphocytic LeukemiaPhase 3NCT05057494
2027-07-15FrexalimabSanofiMultiple SclerosisPhase 3NCT07325292
2027-07-18AvacopanAmgen, Vifor PharmaVasculitisPhase 3NCT06321601
2027-07-21S-1, CapecitabineNordic Group B.V., Taiho Pharmaceutical, Cheplapharm Arzneimittel GmbHGastric CancerPhase 3NCT04997837
2027-07-22AlimatravirMerck & Co.HIV, HIV Pre-Exposure ProphylaxisPhase 3NCT07044297
2027-07-22Everolimus, Fulvestrant, Exemestane, PrifetrastatNovartis, AstraZeneca, PfizerHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT07062965
2027-07-23rilzabrutinibSanofiSickle Cell DiseasePhase 3NCT06975865
2027-07-27BaxdrostatAstraZeneca, RochePrimary HyperaldosteronismPhase 3NCT07007793
2027-07-28Durvalumab, Datopotamab DeruxtecanAstraZeneca, Daiichi SankyoBreast CancerPhase 3NCT06103864
2027-07-28Nomelcitinib (D-2570)InventisBioPsoriasisPhase 3NCT07130604
2027-07-30AtezolizumabChugai Pharma, RocheMesotheliomas PleuralPhase 3NCT04996017
2027-07-30Daratumumab, Pomalidomide, TalquetamabJohnson & Johnson, Bristol-Myers SquibbMultiple MyelomaPhase 3NCT05455320
2027-07-30faricimabChugai Pharma, RocheAge-Related Macular Degeneration, Wet Age-Related Macular DegenerationPhase 3NCT05904028
2027-07-30PF-06651600PfizerVitiligoPhase 3NCT06072183
2027-07-30CrisugabalinHaisco Pharmaceutical GroupCentral Neuropathic PainPhase 3NCT06422117
2027-07-30Sodium zirconium cyclosilicateAstraZenecaChronic Kidney DiseasePhase 3NCT06578533
2027-07-30PembrolizumabMerck & Co.Non-Small Cell Lung CancerPhase 3NCT06635824
2027-07-30Laroprovstat, Rosuvastatin, laroprovstat/rosuvastatinAstraZeneca, ShionogiAtherosclerotic Cardiovascular DiseasePhase 3NCT07619131
2027-07-31metreleptinChiesi FarmaceuticiLipodystrophy, Diabetes, HyperlipidemiaPhase 3NCT02262832
2027-07-31RibociclibNovartisBreast CancerPhase 3NCT04055493
2027-07-31Sintilimab, BevacizumabInnovent Biologics, RocheHepatocellular CarcinomaPhase 3NCT05985798
2027-07-31ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceLimited-stage Small Cell Lung Cancer (LS-SCLC)Phase 3NCT06095583
2027-07-31VonaprumentAnnexon, Inc.Age-Related Macular Degeneration, Geographic AtrophyPhase 3NCT06510816
2027-07-31Cemiplimab, Ateganosine (THIO)Regeneron Pharmaceuticals, Maia BiotechnologyNon-Small Cell Lung CancerPhase 3NCT06908304
2027-07-31SerplulimabAbbott, Accord Healthcare, EisaiLocally Advanced Rectal Cancer (LARC), Immunotherapy, Radiotherapy, Total Neoadjuvant Therapy, Anal Function PreservationPhase 3NCT07020247
2027-07-31Semaglutide (Ozempic)Novo NordiskAcute Ischemic StrokePhase 3NCT07030621

August 2027

Primary completionDrugDeveloperIndicationPhaseStudy
2027-08 (month only)Bortezomib, Thalidomide, DexamethasoneJanssen, Takeda Pharmaceutical Company, Bristol-Myers SquibbMultiple MyelomaPhase 3NCT00572169
2027-08 (month only)CapecitabineCheplapharm Arzneimittel GmbHAdenocarcinoma of the RectumPhase 2/3NCT02945566
2027-08 (month only)NivolumabBristol-Myers Squibb, Ono PharmaceuticalHead and Neck Squamous Cell CarcinomaPhase 3NCT03576417
2027-08 (month only)VenetoclaxAbbVie, RocheAcute Myeloid Leukemia, Multiple Myeloma, Chronic Lymphocytic LeukemiaPhase 3NCT03844048
2027-08 (month only)Bortezomib, Lenalidomide, Isatuximab, DexamethasoneJanssen, Takeda Pharmaceutical Company, Bristol-Myers SquibbMultiple MyelomaPhase 2/3NCT05665140
2027-08 (month only)DalcetrapibDalCor Pharmaceuticals, ShionogiAtherosclerotic Cardiovascular DiseasePhase 3NCT05918861
2027-08 (month only)Lisaftoclax, AcalabrutinibAscentage Pharma Group Inc., AstraZenecaCLL/SLLPhase 3NCT06319456
2027-08 (month only)Equecabtagene autoleucelIASO BiotherapeuticsMultiple MyelomaPhase 3NCT06464991
2027-08 (month only)risankizumab, vedolizumabAbbVie, Boehringer Ingelheim, Takeda Pharmaceutical CompanyUlcerative ColitisPhase 3NCT06880744
2027-08 (month only)ObudanersenIonis PharmaceuticalsAngelman SyndromePhase 3NCT06914609
2027-08 (month only)orforglipronChugai Pharma, Eli LillyObesityPhase 3NCT06972459
2027-08 (month only)orforglipronChugai Pharma, Eli LillyObesity, Type 2 DiabetesPhase 3NCT06972472
2027-08 (month only)BHV-8000Biohaven, Hangzhou Highlightll PharmaceuticalParkinson's DiseasePhase 2/3NCT06976268
2027-08 (month only)orforglipronChugai Pharma, Eli LillyObesity, Type 2 DiabetesPhase 3NCT06993792
2027-08 (month only)HRS-8080Jiangsu Hengrui PharmaceuticalsHR+/HER2- Metastatic Breast CancerPhase 3NCT07024173
2027-08 (month only)CentanafadineOtsuka HoldingsAttention Deficit Hyperactivity DisorderPhase 2/3NCT07086313
2027-08 (month only)CentanafadineOtsuka HoldingsAttention Deficit Hyperactivity DisorderPhase 3NCT07087327
2027-08 (month only)TapinarofOrganon, Shionogi, Torii PharmaceuticalAtopic DermatitisPhase 3NCT07265479
2027-08 (month only)Bempedoic acidCSL Seqirus, Daiichi Sankyo, Esperion TherapeuticsAtherosclerotic Cardiovascular DiseasePhase 3NCT07440381
2027-08 (month only)Regorafenib, FruquintinibBayer, HUTCHMED, Takeda Pharmaceutical CompanyColorectal CancerPhase 3NCT07483684
2027-08 (month only)palopegteriparatideAscendis Pharma A/S, Pendopharm, TeijinHypoparathyroidismPhase 3NCT07706764
2027-08 (month only)Cariprazine (Vraylar)AbbVie, Gedeon Richter, Tanabe Pharma CorporationSchizophreniaPhase 2/3NCT07722728
2027-08 (month only)Brexpiprazole (Rexulti)H. Lundbeck, Otsuka HoldingsSchizophreniaPhase 2/3NCT07742280
2027-08 (month only)SuzetrigineVertex PharmaceuticalsPost-operative Pain, DIEP Flap Breast Reconstruction, DIEP Flap, Opioid, Suzetrigine, ERASPhase 3NCT07839715
2027-08 (month only)DenifanstatAscletis Pharma, Sagimet Biosciences Inc.Acne VulgarisPhase 3NCT07863193
2027-08 (month only)Nalbuphine ERTrevi Therapeutics, Inc.Chronic Cough in Idiopathic Pulmonary FibrosisPhase 3NCT07868419
2027-08-01Pyrotinib, PertuzumabDr. Reddy's Laboratories, HLB Life Science, Jiangsu Hengrui PharmaceuticalsBreast CancerPhase 3NCT04973319
2027-08-01AdebrelimabJiangsu Hengrui PharmaceuticalsSmall Cell Lung CancerPhase 3NCT05496166
2027-08-01CadonilimabAkesoNasopharyngeal Carcinoma, Nasopharyngeal CancerPhase 3NCT05587374
2027-08-01BFB759Bluefin BiomedicineHidradenitis SuppurativaPhase 2/3NCT07287644
2027-08-01Roflumilast (Daliresp)AstraZenecaNAFLD (Nonalcoholic Fatty Liver Disease)Phase 2/3NCT07900087
2027-08-02OsimertinibAstraZenecaNon-Small Cell Lung CancerPhase 3NCT05120349
2027-08-04ElranatamabPfizerMultiple MyelomaPhase 3NCT05317416
2027-08-07TofersenBiogen, Ionis PharmaceuticalsAmyotrophic Lateral SclerosisPhase 3NCT04856982
2027-08-07CapecitabineCheplapharm Arzneimittel GmbHNeuroendocrine Neoplasia's (NENs), Neuroendocrine Tumor GEP Grade 1-3, Neuroendocrine Gastroenteropancreatic TumourPhase 3NCT07185672
2027-08-09GolcadomideBristol-Myers SquibbLarge B-Cell LymphomaPhase 3NCT06356129
2027-08-10ZigakibartNovartisChronic Kidney Disease, IgA NephropathyPhase 3NCT05852938
2027-08-17Nivolumab, AtigotatugBristol-Myers Squibb, Ono PharmaceuticalSmall Cell Lung CancerPhase 3NCT06646276
2027-08-17baricitinibEli Lilly, IncyteAcute Ichemic Stroke, Anterior Cerebral Artery Stroke, BaricitinibPhase 2/3NCT07449910
2027-08-20ZodasiranArrowhead PharmaceuticalsHomozygous Familial HypercholesterolemiaPhase 3NCT07037771
2027-08-20maridebart cafraglutideAmgenObesityPhase 3NCT07225686
2027-08-24RavulizumabAstraZenecaMyasthenia Gravis, Generalized Myasthenia GravisPhase 3NCT07596784
2027-08-25ApatinibAdvenchen Laboratories, Elevar Therapeutics, Inc., HLB Life ScienceGastric Cancer, SurgeryPhase 3NCT07314203
2027-08-27EtavopivatNovo NordiskSickle Cell DiseasePhase 3NCT06612268
2027-08-27BLU-5937GlaxoSmithKlineRefractory Chronic CoughPhase 3NCT07650084
2027-08-28HDM1005Hangzhou Zhongmei Huadong PharmaceuticalType 2 DiabetesPhase 3NCT07394114
2027-08-30MethotrexateInvestigate the Effect(s) of Methotrexate Treatment on Arthritis Disease SeverityPhase 3NCT04483466
2027-08-30VC005Hangzhou Zhongmei Huadong Pharmaceutical, Jiangsu Vcare PharmatechAtopic DermatitisPhase 3NCT06723080
2027-08-30Venetoclax, AzacitidineAbbVie, Roche, Bristol-Myers SquibbAcute Myeloid LeukemiaPhase 3NCT07132684
2027-08-30VC005Hangzhou Zhongmei Huadong Pharmaceutical, Jiangsu Vcare PharmatechActive Ankylosing SpondylitisPhase 3NCT07172360
2027-08-30maridebart cafraglutideAmgenObstructive Sleep ApneaPhase 3NCT07226765
2027-08-30HDM1005Hangzhou Zhongmei Huadong PharmaceuticalType 2 DiabetesPhase 3NCT07417306
2027-08-31DurvalumabAstraZenecaNon-Small Cell Lung CancerPhase 3NCT04465968
2027-08-31Atezolizumab, BevacizumabChugai Pharma, RocheVenous ThrombosisPhase 3NCT04649489
2027-08-31onabotulinumtoxinAAbbVieTransfer Dysphagia, Oropharyngeal Dysphagia, Cricopharyngeus Muscle DysfunctionPhase 2/3NCT04695600
2027-08-31Iparomlimab and tuvonralimabQilu PharmaceuticalNon-Small Cell Lung CancerPhase 3NCT05487391
2027-08-31tovecimigCompass TherapeuticsBiliary Tract CancerPhase 2/3NCT05506943
2027-08-31GotistobartOncoC4, Inc.Non-Small Cell Lung CancerPhase 3NCT05671510
2027-08-31Obinutuzumab, tocilizumabRoche, Chugai PharmaLymphomaPhase 3NCT06084936
2027-08-31Cannabidiol (Epidiolex)GW Pharmaceuticals, Jazz PharmaceuticalsGeneralized Anxiety Disorder (GAD), Anxiety DisordersPhase 3NCT07123467
2027-08-31InebilizumabAmgen, Hansoh Pharmaceutical Group, Tanabe Pharma CorporationNeuromyelitis Optica (NMO), Neuromyelitis Optica Spectrum Disorders (NMOSD)Phase 3NCT07132398
2027-08-31Ferric carboxymaltoseDaiichi Sankyo, Vifor PharmaScoliosis Correction, Iron Deficiency, Transfusion Blood, Surgery Complications, Spinal Fusion, Scoliosis Idiopathic Adolescent, Scoliosis NeuromuscularPhase 2/3NCT07217873

September 2027

Primary completionDrugDeveloperIndicationPhaseStudy
2027-09 (month only)upadacitinibAbbVieCrohn's DiseasePhase 3NCT03345823
2027-09 (month only)NivolumabBristol-Myers Squibb, Ono PharmaceuticalMelanomaPhase 3NCT04309409
2027-09 (month only)Ibrutinib, Venetoclax, ObinutuzumabAbbVie, Johnson & Johnson, RocheChronic Lymphoid LeukemiaPhase 3NCT04608318
2027-09 (month only)Blinatumomab, PonatinibAmgen, Incyte, Otsuka HoldingsAcute Lymphoblastic LeukemiaPhase 3NCT04722848
2027-09 (month only)Olanzapine/samidorphan (Lybalvi)Alkermes plcSchizophrenia, Bipolar DisorderPhase 3NCT04987229
2027-09 (month only)Brexpiprazole (Rexulti)H. Lundbeck, Otsuka HoldingsSchizophreniaPhase 3NCT05325645
2027-09 (month only)BlinatumomabAmgenAcute Lymphoblastic LeukemiaPhase 3NCT05327894
2027-09 (month only)Olanzapine (Zyprexa), DexamethasoneCheplapharm Arzneimittel GmbH, Eli LillyOut-Of-Hospital Cardiac Arrest, Post-Cardiac Arrest SyndromePhase 3NCT05895838
2027-09 (month only)DapagliflozinAstraZeneca, Ono PharmaceuticalChronic Kidney DiseasePhase 3NCT05944016
2027-09 (month only)LenalidomideBristol-Myers Squibb, Celgene CorporationMarginal Zone LymphomaPhase 3NCT06006117
2027-09 (month only)ModafinilApotex Inc.Stroke, Fatigue, Modafinil, ExercisePhase 3NCT06354985
2027-09 (month only)EverolimusNovartisHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT06382948
2027-09 (month only)ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceUrothelial CarcinomaPhase 3NCT06592326
2027-09 (month only)SHR-1703Jiangsu Hengrui PharmaceuticalsAsthma With Eosinophilic PhenotypePhase 3NCT06653322
2027-09 (month only)Omecamtiv mecarbilCorxel Pharmaceuticals, CytokineticsHeart Failure, Heart Failure with Reduced Ejection FractionPhase 3NCT06736574
2027-09 (month only)orforglipronChugai Pharma, Eli LillyObesity, HypertensionPhase 3NCT06948422
2027-09 (month only)orforglipronChugai Pharma, Eli LillyObesity, HypertensionPhase 3NCT06948435
2027-09 (month only)orforglipronChugai Pharma, Eli LillyObesity, HypertensionPhase 3NCT06952530
2027-09 (month only)retatrutideEli LillyObesityPhase 3NCT07035093
2027-09 (month only)Gamgertamig (CM336)Gilead Sciences, Keymed Biosciences, Lakefront Biotherapeutics NVMultiple MyelomaPhase 3NCT07181239
2027-09 (month only)DanicamtivBristol-Myers Squibb, KardiganSymptomatic Genetic Dilated CardiomyopathyPhase 2/3NCT07210723
2027-09 (month only)Olanzapine (Zyprexa)Cheplapharm Arzneimittel GmbH, Eli LillyMultiple MyelomaPhase 3NCT07413809
2027-09 (month only)Lysergide tartrate (LSD)Definium TherapeuticsMajor Depressive DisorderPhase 3NCT07592689
2027-09 (month only)Rinatabart sesutecan (Rina-S)GenmabOvarian CancerPhase 3NCT07604766
2027-09 (month only)viloxazineKnight Therapeutics, M8 Pharmaceuticals, Supernus PharmaceuticalsAttention Deficit Hyperactivity DisorderPhase 3NCT07678827
2027-09 (month only)TQH3906Sino BiopharmaceuticalPsoriasisPhase 3NCT07724366
2027-09 (month only)SSGJ-611Sunshine Guojian PharmaceuticalAtopic DermatitisPhase 3NCT07767253
2027-09-01Carfilzomib, Lenalidomide, DexamethasoneAmgen, Ono Pharmaceutical, Bristol-Myers SquibbMultiple MyelomaPhase 3NCT04096066
2027-09-01TicagrelorAstraZenecaAtherosclerotic Cardiovascular DiseasePhase 3NCT05476991
2027-09-01Durvalumab, Datopotamab DeruxtecanAstraZeneca, Daiichi SankyoBreast CancerPhase 3NCT05629585
2027-09-01Bevacizumab, Iparomlimab and tuvonralimab, CapecitabineRoche, Qilu Pharmaceutical, Cheplapharm Arzneimittel GmbHHepatocellular CarcinomaPhase 2/3NCT05976568
2027-09-01SintilimabInnovent BiologicsEsophageal Squamous Cell Carcinoma (ESCC)Phase 3NCT07016737
2027-09-01PhenytoinViatrisGingival RecessionPhase 2/3NCT07590375
2027-09-07Xanomeline/trospium chlorideBristol-Myers Squibb, Zai LabAlzheimer's DiseasePhase 3NCT05980949
2027-09-10DexamethasoneInflammatory ResponsePhase 3NCT05323149
2027-09-13vedolizumabTakeda Pharmaceutical CompanyCrohn's DiseasePhase 3NCT04779320
2027-09-15HetrombopagJiangsu Hengrui PharmaceuticalsThrombocytopenia, Hepatic Interventional ProcedurePhase 3NCT07925398
2027-09-20SHR-A1904Jiangsu Hengrui PharmaceuticalsSecond-line Advanced or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaPhase 3NCT06649292
2027-09-21VAY736NovartisLupus NephritisPhase 3NCT05126277
2027-09-21BerobenatidePfizerObesityPhase 3NCT07311850
2027-09-23ZemocimigRocheHemophilia APhase 3NCT07416526
2027-09-24vedolizumabTakeda Pharmaceutical CompanyUlcerative ColitisPhase 3NCT03221036
2027-09-24NusinersenBiogen, Ionis PharmaceuticalsSpinal Muscular AtrophyPhase 3NCT05067790
2027-09-24Rituximab, Zilovertamab vedotinBiogen, Chugai Pharma, RocheDiffuse Large B-Cell LymphomaPhase 2/3NCT05139017
2027-09-24UBT251Novo Nordisk, United Bio-Technology (Hengqin)Type 2 DiabetesPhase 3NCT07659574
2027-09-24TarlatamabAmgenSmall Cell Lung CancerPhase 3NCT07778316
2027-09-28Cemiplimab, FianlimabRegeneron PharmaceuticalsNon-Small Cell Lung CancerPhase 2/3NCT05785767
2027-09-28BomedemstatMerck & Co.Essential ThrombocythemiaPhase 3NCT06456346
2027-09-28AxatilimabIncyte, SyndaxChronic Graft-versus-Host DiseasePhase 3NCT06585774
2027-09-28IbuzatrelvirPfizerCOVID-19Phase 3NCT07013474
2027-09-29metforminType 1 Diabetes, Peripheral Arterial CalcificationPhase 3NCT04583462
2027-09-29ustekinumabJohnson & JohnsonUlcerative Colitis, Crohn's Disease, Psoriatic ArthritisPhase 3NCT05092269
2027-09-29UBT251Novo Nordisk, United Bio-Technology (Hengqin)ObesityPhase 3NCT07648225
2027-09-30Pembrolizumab, pemetrexedMerck & Co., Eli LillyNon-Small Cell Lung CancerPhase 3NCT03793179
2027-09-30Methotrexate, Blinatumomab, DexamethasoneAmgenAcute Lymphoblastic LeukemiaPhase 3NCT03914625
2027-09-30Durvalumab, MethotrexateAstraZenecaUrothelial CarcinomaPhase 2/3NCT04628767
2027-09-30SaruparibAstraZenecaProstate CancerPhase 3NCT06120491
2027-09-30tradipitantVanda PharmaceuticalsMotion SicknessPhase 3NCT06138613
2027-09-30Elexacaftor / tezacaftor / ivacaftorVertex PharmaceuticalsCystic FibrosisPhase 3NCT06460506
2027-09-30SelinexorA. Menarini, Antengene Corporation Limited, FORUS Therapeutics Inc.Acute Myeloid LeukemiaPhase 3NCT06613035
2027-09-30MevrometostatPfizerMetastatic Castration-Resistant Prostate CancerPhase 3NCT06629779
2027-09-30CB03-154Zhimeng BiopharmaAmyotrophic Lateral SclerosisPhase 2/3NCT07082192
2027-09-30TislelizumabBeOne MedicinesColonic Neoplasms, Neoadjuvant Therapy, Immune Checkpoint InhibitorsPhase 3NCT07132008
2027-09-30Venetoclax, Chidamide, AzacitidineAbbVie, Roche, Chipscreen BiosciencesAcute Myeloid LeukemiaPhase 3NCT07514936
2027-09-30HSK39004AirNexis Therapeutics, Haisco Pharmaceutical GroupChronic Obstructive Pulmonary DiseasePhase 3NCT07583849
2027-09-30CleminorextonEli LillyNarcolepsyPhase 2/3NCT07598708
2027-09-30CPO301, EnlonstobartConjupro Biotherapeutics, Inc., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Hangzhou Sumgen Biotech Co., Ltd.Non-Small Cell Lung CancerPhase 3NCT07633873

October 2027

Primary completionDrugDeveloperIndicationPhaseStudy
2027-10 (month only)RemimazolamJiangsu Hengrui PharmaceuticalsPediatric ALLPhase 2/3NCT04851717
2027-10 (month only)PirtobrutinibEli LillyChronic Lymphocytic LeukemiaPhase 3NCT05254743
2027-10 (month only)ImlunestrantEli LillyBreast CancerPhase 3NCT05514054
2027-10 (month only)Tirzepatide (Zepbound)Eli LillyObesityPhase 3NCT05556512
2027-10 (month only)zanubrutinibBeOne MedicinesPrimary Membranous NephropathyPhase 2/3NCT05707377
2027-10 (month only)pegunigalsidase alfaChiesi Farmaceutici, Protalix BioTherapeutics, Inc.Fabry DiseasePhase 2/3NCT05710692
2027-10 (month only)TadalafilEli Lilly, Nippon Shinyaku, United TherapeuticsPulmonary Hypertension, Chronic Obstructive Pulmonary DiseasePhase 3NCT05844462
2027-10 (month only)Tirzepatide (Zepbound)Eli LillyObesityPhase 3NCT06439277
2027-10 (month only)Olanzapine (Zyprexa)Cheplapharm Arzneimittel GmbH, Eli LillyMultiple Myeloma, Autologous Stem Cell TransplantationPhase 3NCT06588413
2027-10 (month only)RituximabBiogen, Chugai Pharma, RocheCIDPPhase 3NCT06714838
2027-10 (month only)Ferric derisomaltoseChina Medical System, Nippon Shinyaku, PfizerPeritoneal Dialysis, Anaemia, Iron Deficiency, AnaemiaPhase 3NCT06884280
2027-10 (month only)DireclidineNeurocrine Biosciences, Nxera PharmaSchizophreniaPhase 3NCT06963034
2027-10 (month only)HRS-5965Jiangsu Hengrui PharmaceuticalsPrimary IgA NephropathyPhase 3NCT07014826
2027-10 (month only)Bevacizumab, SerplulimabRoche, Abbott, Accord HealthcareRectal CancerPhase 2/3NCT07134218
2027-10 (month only)SHR-1918Jiangsu Hengrui PharmaceuticalsHyperlipidemiaPhase 3NCT07230730
2027-10 (month only)BofanglutideA. Menarini, Gan & Lee Pharmaceuticals, JW PharmaceuticalType 2 DiabetesPhase 3NCT07628985
2027-10 (month only)LurasidoneAngelini Pharma S.p.A. (A.C.R.A.F. S.p.A.), Sumitomo PharmaMajor Depressive Disorder (MDD), Major Depressive Disorder With Psychotic FeaturesPhase 3NCT07781293
2027-10 (month only)ElismetrepTriGemX BioMigrainePhase 3NCT07816367
2027-10 (month only)DexamethasoneRib Fractures, Acute Pain, Thoracic TraumaPhase 2/3NCT07827157
2027-10 (month only)DexamethasonePostoperative Pain, Total Hip Arthroplasty (THA)Phase 3NCT07847047
2027-10 (month only)BevacizumabRocheDiabetic Macular Edema (DME)Phase 3NCT07897630
2027-10 (month only)SHR-3167Jiangsu Hengrui PharmaceuticalsType 2 DiabetesPhase 3NCT07920939
2027-10-01AnakinraSwedish Orphan Biovitrum AB (publ)PericarditisPhase 3NCT05805930
2027-10-01Semaglutide (Ozempic)Novo NordiskDiabetes Mellitus, Type 1Phase 3NCT05819138
2027-10-01Trastuzumab DeruxtecanAstraZeneca, Daiichi SankyoHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT05950945
2027-10-01RituximabBiogen, Chugai Pharma, RocheLarge B-Cell LymphomaPhase 3NCT06047080
2027-10-01CamrelizumabElevar Therapeutics, Inc., Jiangsu Hengrui PharmaceuticalsRectal CancerPhase 3NCT06229041
2027-10-01IbuzatrelvirPfizerCOVID-19Phase 3NCT06679140
2027-10-01Pembrolizumab, NivolumabMerck & Co., Bristol-Myers Squibb, Ono PharmaceuticalSolid TumorsPhase 3NCT07174453
2027-10-01FinerenoneBayerKidney Transplantation Recipients, Proteinuria PatientsPhase 3NCT07356388
2027-10-01VG081821ACVimgreen PharmaceuticalsParkinson's DiseasePhase 2/3NCT07725562
2027-10-01TegileridineJiangsu Hengrui PharmaceuticalsPain Management, Overweight , Obesity, RespirationPhase 3NCT07844512
2027-10-04albuterol / budesonideAstraZenecaAsthmaPhase 3NCT06471257
2027-10-07QLC7401Qilu Pharmaceutical, Suzhou Ribo Life ScienceAtherosclerotic Cardiovascular DiseasePhase 3NCT07444086
2027-10-10BlinatumomabAmgenAcute Lymphoblastic LeukemiaPhase 3NCT07723911
2027-10-11Laroprovstat, Rosuvastatin, laroprovstat/rosuvastatinAstraZeneca, ShionogiAtherosclerotic Cardiovascular DiseasePhase 3NCT07930507
2027-10-12Durvalumab, TremelimumabAstraZeneca, MedImmune LLCHepatocellular CarcinomaPhase 3NCT07027436
2027-10-12INCB123667IncyteOvarian CancerPhase 3NCT07214779
2027-10-12BerobenatidePfizerObesity, Type 2 DiabetesPhase 3NCT07400653
2027-10-13albuterol / budesonideAstraZenecaAsthmaPhase 3NCT06307665
2027-10-15Azacitidine, IvosidenibBristol-Myers Squibb, ServierAcute Myeloid LeukemiaPhase 3NCT05907057
2027-10-15Puxitatug samrotecanAstraZenecaEndometrial CancerPhase 3NCT07044336
2027-10-16Nivolumab, brenetafuspBristol-Myers Squibb, Ono Pharmaceutical, Immunocore Holdings plcMelanomaPhase 3NCT06112314
2027-10-18IptacopanNovartisParoxysmal Nocturnal HemoglobinuriaPhase 3NCT04747613
2027-10-18AlimatravirMerck & Co.HIV, HIV Pre-Exposure ProphylaxisPhase 3NCT07071623
2027-10-27guselkumabJohnson & JohnsonCrohn's DiseasePhase 3NCT05923073
2027-10-28Pembrolizumab, OlaparibMerck & Co., AstraZenecaSmall Cell Lung CancerPhase 3NCT04624204
2027-10-28dupilumabRegeneron Pharmaceuticals, SanofiPrurigo NodularisPhase 3NCT06293053
2027-10-28SevabertinibBayerNon-Small Cell Lung CancerPhase 3NCT06452277
2027-10-28nemolizumabChugai Pharma, Galderma, MaruhoAtopic DermatitisPhase 3NCT07762833
2027-10-29DepemokimabGlaxoSmithKlineHypereosinophilic SyndromePhase 3NCT05334368
2027-10-30apraglutideIronwood PharmaceuticalsShort Bowel SyndromePhase 3NCT05018286
2027-10-30RoxadustatAstellas Pharma, AstraZeneca, Kyntra BioChronic Kidney DiseasePhase 3NCT05970172
2027-10-30Fulvestrant, Fluzoparib, DalpiciclibAstraZeneca, Jiangsu Hengrui PharmaceuticalsHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT06612814
2027-10-30Tislelizumab, CapecitabineBeOne Medicines, Cheplapharm Arzneimittel GmbHMetastatic Gastric Adenocarcinoma, Gastroesophageal Junction AdenocarcinomaPhase 3NCT07043400
2027-10-30GabapentinPfizer, ViatrisPain, Postoperative, Osteoarthritis, KneePhase 2/3NCT07047040
2027-10-30NeovasculgenArtgen BiotechIC, Hunner Type Interstitial Cystitis, Bladder Pain SyndromePhase 2/3NCT07459790
2027-10-31N-acetylcysteineApotex Inc., Phebra Pty LtdInfluenzaPhase 3NCT03900988
2027-10-31Nivolumab, RamucirumabBristol-Myers Squibb, Ono Pharmaceutical, Eli LillyGastric CancerPhase 2/3NCT06203600
2027-10-31CadonilimabAkesoAdvanced Ovarian Cancer, AK104(PD-1/CTLA-4 Bispecial Antibody), Chemotherapy, Efficacy, SafetyPhase 3NCT06542549
2027-10-31ASKC202, LimertinibJiangsu Aosaikang Pharmaceutical, Innovent BiologicsNon-Small Cell Lung CancerPhase 3NCT07109531
2027-10-31pemetrexed, FudotinibEli Lilly, Guangzhou JOYO PharmaNon-Small Cell Lung CancerPhase 3NCT07154368
2027-10-31mazdutideEli Lilly, Innovent BiologicsObesityPhase 3NCT07255209
2027-10-31ribupatideJiangsu Hengrui Pharmaceuticals, Kailera TherapeuticsObesityPhase 3NCT07670884

November 2027

Primary completionDrugDeveloperIndicationPhaseStudy
2027-11 (month only)Carfilzomib, Lenalidomide, DexamethasoneAmgen, Ono Pharmaceutical, Bristol-Myers SquibbMultiple MyelomaPhase 3NCT02659293
2027-11 (month only)PirtobrutinibEli LillyMantle Cell LymphomaPhase 3NCT04662255
2027-11 (month only)DonanemabEli LillyAlzheimer's DiseasePhase 3NCT05026866
2027-11 (month only)Treprostinil (Tyvaso)United TherapeuticsProgressive Pulmonary Fibrosis, Interstitial Lung DiseasePhase 3NCT05943535
2027-11 (month only)FinerenoneBayerHeart FailurePhase 3NCT06008197
2027-11 (month only)Empagliflozin, FinerenoneBoehringer Ingelheim, Eli Lilly, BayerHeart FailurePhase 3NCT06024746
2027-11 (month only)OlomorasibEli LillyNon-Small Cell Lung CancerPhase 3NCT06119581
2027-11 (month only)Ubrogepant (Ubrelvy)AbbVieMigrainePhase 3NCT06417775
2027-11 (month only)soquelitinibAngel Pharmaceuticals, Corvus PharmaceuticalsPeripheral T-Cell LymphomaPhase 3NCT06561048
2027-11 (month only)tasimelteonVanda PharmaceuticalsInsomnia DisorderPhase 3NCT06953869
2027-11 (month only)Iloperidone (Fanapt)Vanda PharmaceuticalsSchizophreniaPhase 3NCT06961968
2027-11 (month only)DireclidineNeurocrine Biosciences, Nxera PharmaSchizophreniaPhase 3NCT07105098
2027-11 (month only)SHR-1819Jiangsu Hengrui PharmaceuticalsAtopic DermatitisPhase 3NCT07309055
2027-11 (month only)efpeglenatideHanmi Pharmaceutical, Laboratorios SanferType 2 DiabetesPhase 3NCT07379333
2027-11 (month only)EnavogliflozinArcera Life Sciences, Daewoong PharmaceuticalType 2 DiabetesPhase 3NCT07619833
2027-11 (month only)CM512Belenos Biosciences, Keymed BiosciencesChronic Rhinosinusitis With Nasal Polyposis (CRSwNP)Phase 3NCT07807826
2027-11-01Methotrexate, Rituximab, DexamethasoneBiogen, Chugai Pharma, RocheAcute Lymphoblastic LeukemiaPhase 3NCT03150693
2027-11-01Venetoclax, AzacitidineAbbVie, Roche, Bristol-Myers SquibbAcute Myeloid Leukemia, Myelodysplastic SyndromesPhase 2/3NCT04256317
2027-11-01Abemaciclib, Ribociclib, Capivasertib, PalbociclibEli Lilly, Novartis, Astex Pharmaceuticals, Inc.HR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT04862663
2027-11-01Durvalumab, Datopotamab DeruxtecanAstraZeneca, Daiichi SankyoNon-Small Cell Lung CancerPhase 3NCT05687266
2027-11-01Olanzapine (Zyprexa)Cheplapharm Arzneimittel GmbH, Eli LillyMisuse, OpioidPhase 3NCT06200181
2027-11-01Azacitidine, IvosidenibBristol-Myers Squibb, ServierMyelodysplastic SyndromesPhase 3NCT06465953
2027-11-01TislelizumabBeOne MedicinesColorectal Cancer, Microsatellite Instability HighPhase 3NCT06520683
2027-11-01SuzetrigineVertex PharmaceuticalsTotal Hip Arthroplasty (THA), Total Hip Arthroplasty \(THA\), Total Hip Replacement, Total Hip Replacement Surgery, Total Hip Replacements, Total Hip Replacement Arthroplasty, Suzetrigine, Pain Management, Pain, Nav 1.8, JOURNAVX, Opioid Cessation, Opioid Consumption, Postoperative, Multimodal Analgesia, Randomized Controlled Trial, Randomized Controlled Study, Randomized Controlled TrialsPhase 3NCT07226700
2027-11-04tozorakimabAstraZenecaViral Lung Infection and Acute Respiratory FailurePhase 3NCT05624450
2027-11-05rilzabrutinibSanofiImmune ThrombocytopeniaPhase 3NCT07007962
2027-11-05Risvutatug rezetecanGlaxoSmithKline, Hansoh Pharmaceutical GroupSmall Cell Lung CancerPhase 3NCT07099898
2027-11-07Semaglutide (Ozempic)Novo NordiskType 2 DiabetesPhase 3NCT03811561
2027-11-08FenfluramineNippon Shinyaku, UCBEpilepsyPhase 3NCT05064878
2027-11-11BexicaserinH. LundbeckEpilepsyPhase 3NCT06908226
2027-11-12spesolimabBoehringer Ingelheim, LEO PharmaPyoderma GangrenosumPhase 3NCT06624670
2027-11-14Exagamglogene autotemcel (Casgevy)CRISPR Therapeutics, Vertex PharmaceuticalsBeta-Thalassemia, Thalassemia, Genetic Diseases, Inborn, Hematologic Diseases, HemoglobinopathiesPhase 3NCT05356195
2027-11-14BofanglutideA. Menarini, Gan & Lee Pharmaceuticals, JW PharmaceuticalObesityPhase 3NCT07493057
2027-11-15Ixoberogene soroparvovecEli LillyWet Age-Related Macular DegenerationPhase 3NCT07482176
2027-11-16Daratumumab, Iberdomide, DexamethasoneJohnson & Johnson, Bristol-Myers SquibbMultiple MyelomaPhase 3NCT04975997
2027-11-17Cadonilimab, CapecitabineAkeso, Cheplapharm Arzneimittel GmbHGastric / Gastroesophageal Junction AdenocarcinomaPhase 3NCT07449780
2027-11-18Ropeginterferon alfa-2b (Besremi)AOP Orphan Pharmaceuticals GmbH, PharmaEssentia CorporationMyelofibrosisPhase 3NCT06468033
2027-11-19Docetaxel, PasritamigSanofi, Johnson & JohnsonMetastatic Castration-Resistant Prostate Cancer, Prostate CancerPhase 3NCT07225946
2027-11-20CamrelizumabElevar Therapeutics, Inc., Jiangsu Hengrui PharmaceuticalsNasopharyngeal CarcinomaPhase 3NCT06669611
2027-11-26VolrustomigAstraZenecaCervical CancerPhase 3NCT06079671
2027-11-26EnlicitideMerck & Co.Atherosclerotic Cardiovascular Disease, HypercholesterolemiaPhase 3NCT07821944
2027-11-30metforminMedulloblastoma, Childhood, Cognitive ImpairmentPhase 3NCT05230758
2027-11-30ExoFloDirect BiologicsAcute Respiratory Distress Syndrome, ARDSPhase 3NCT05354141
2027-11-30Clifutinib BesylateShenyang Sunshine Pharmaceutical, Sunshine Lake PharmaAcute Myeloid LeukemiaPhase 3NCT05586074
2027-11-30Risvutatug rezetecanGlaxoSmithKline, Hansoh Pharmaceutical GroupSmall Cell Lung CancerPhase 3NCT06526624
2027-11-30Capivasertib, FulvestrantAstex Pharmaceuticals, Inc., AstraZenecaHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT06764186
2027-11-30RavulizumabAstraZenecaDelayed Graft Function, DGF, Kidney TransplantPhase 3NCT06830798
2027-11-30Regorafenib, Fruquintinib, Anbenitamab repodatecanBayer, HUTCHMED, Takeda Pharmaceutical CompanyColorectal CancerPhase 3NCT07384377

December 2027

Primary completionDrugDeveloperIndicationPhaseStudy
2027-12 (month only)Cetuximab, AvelumabEli Lilly, Merck KGaAHNSCCPhase 3NCT02999087
2027-12 (month only)MasitinibAB ScienceAmyotrophic Lateral SclerosisPhase 3NCT03127267
2027-12 (month only)metforminCognitive DeclinePhase 3NCT04511416
2027-12 (month only)GemcitabineEli LillyBladder Cancer, Bladder Urothelial CarcinomaPhase 3NCT04574960
2027-12 (month only)RituximabBiogen, Chugai Pharma, RocheIdiopathic Membranous NephropathyPhase 3NCT04745728
2027-12 (month only)Naloxone (Narcan)Emergent BioSolutionsOpioid-use DisorderPhase 2/3NCT04893525
2027-12 (month only)AbemaciclibEli LillyAdvanced Dedifferentiated LiposarcomaPhase 3NCT04967521
2027-12 (month only)PembrolizumabMerck & Co.Endometrial CancerPhase 3NCT05077215
2027-12 (month only)BevacizumabRocheAge-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration, BRVO - Branch Retinal Vein Occlusion, Diabetic Macular EdemaPhase 3NCT05112861
2027-12 (month only)RituximabBiogen, Chugai Pharma, RocheAnti-MAG NeuropathyPhase 3NCT05136976
2027-12 (month only)TagitanlimabSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Nasopharyngeal CarcinomaPhase 3NCT05294172
2027-12 (month only)Tividenofusp alfaDenali TherapeuticsMucopolysaccharidosis Type IIPhase 2/3NCT05371613
2027-12 (month only)mirikizumabEli LillyCrohn's DiseasePhase 3NCT05509777
2027-12 (month only)Colchicine (cardiovascular)Agepha PharmaDiabete Type 2, Cardiovascular DiseasesPhase 3NCT05633810
2027-12 (month only)lebrikizumabAlmirall, Eli LillyAtopic DermatitisPhase 3NCT05735483
2027-12 (month only)AlmonertinibGlenmark Pharmaceuticals Ltd., Hansoh Pharmaceutical GroupNon-Small Cell Lung CancerPhase 3NCT05800223
2027-12 (month only)CadonilimabAkesoNasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy, ChemotherapyPhase 3NCT05941741
2027-12 (month only)tocilizumabChugai Pharma, RocheGiant Cell ArteritisPhase 3NCT06037460
2027-12 (month only)RetifanlimabIncyteBreast Cancer, Metastatic Breast Cancer, Breast Neoplasm, Breast Cancer Metastatic, End Stage CancerPhase 3NCT06072612
2027-12 (month only)Nexiguran ziclumeranRegeneron PharmaceuticalsTransthyretin Amyloidosis with CardiomyopathyPhase 3NCT06128629
2027-12 (month only)Selinexor, Carfilzomib, Pomalidomide, Bortezomib, Elotuzumab, Etentamig, DexamethasoneA. Menarini, Antengene Corporation Limited, FORUS Therapeutics Inc.Multiple MyelomaPhase 3NCT06158841
2027-12 (month only)Trastuzumab pamirtecanBioNTech, DualityBio Inc.HER2-Positive Breast CancerPhase 3NCT06265428
2027-12 (month only)Semaglutide (Ozempic)Novo NordiskType 1 Diabetes, Diabetes MellitusPhase 2/3NCT06387199
2027-12 (month only)NiraparibGlaxoSmithKline, Zai LabGlioblastomaPhase 3NCT06388733
2027-12 (month only)Semaglutide (Wegovy)Novo NordiskObesityPhase 3NCT06499857
2027-12 (month only)DocetaxelSanofiMetastatic Castration-Resistant Prostate Cancer, Prostate CancerPhase 3NCT06520345
2027-12 (month only)PiclidenosonCan-Fite BioPharma, China Medical System, Gebro Pharma GmbHPsoriasisPhase 3NCT06643260
2027-12 (month only)orforglipronChugai Pharma, Eli LillyObesityPhase 3NCT06672939
2027-12 (month only)BuntanetapAnnovis Bio (NYSE American: ANVS)Alzheimer's Disease, Early Alzheimer's DiseasePhase 3NCT06709014
2027-12 (month only)dulaglutideEli LillyType 2 DiabetesPhase 3NCT06739122
2027-12 (month only)Pomalidomide, QL2109, DexamethasoneBristol-Myers Squibb, Qilu PharmaceuticalMultiple MyelomaPhase 3NCT06742138
2027-12 (month only)SolriamfetolAxsome Therapeutics, Pharmanovia, SK Biopharmaceuticals Co., Ltd.Binge-Eating DisorderPhase 3NCT06878976
2027-12 (month only)ADSTEMEHL BioOsteoarthritis KneePhase 2/3NCT06893250
2027-12 (month only)MigalastatAmicus Therapeutics, BioMarin PharmaceuticalFabry DiseasePhase 3NCT06904261
2027-12 (month only)CentanafadineOtsuka HoldingsAttention Deficit Hyperactivity DisorderPhase 3NCT06926829
2027-12 (month only)CentanafadineOtsuka HoldingsAttention Deficit Hyperactivity DisorderPhase 2/3NCT06931080
2027-12 (month only)EmpagliflozinBoehringer Ingelheim, Eli LillyCongenital Heart DiseasePhase 3NCT06955260
2027-12 (month only)FurmonertinibAllist Pharmaceuticals, ArriVent BioPharmaNon-Small Cell Lung CancerPhase 3NCT06956001
2027-12 (month only)ImeroprubartHanAll BioPharma, Immunovant, Inc., Roivant Sciences Ltd.Myasthenia GravisPhase 3NCT07039916
2027-12 (month only)TislelizumabBeOne MedicinesRectal CancerPhase 3NCT07132463
2027-12 (month only)QLS32015Qilu PharmaceuticalMultiple MyelomaPhase 3NCT07138209
2027-12 (month only)Trastuzumab brengitecanSichuan Baili PharmaceuticalNon-Small Cell Lung CancerPhase 3NCT07178795
2027-12 (month only)DapagliflozinAstraZeneca, Ono PharmaceuticalAtrial Fibrillation (AF)Phase 3NCT07187570
2027-12 (month only)Trastuzumab rezetecanGlenmark Pharmaceuticals Ltd., Jiangsu Hengrui PharmaceuticalsHER2-Positive Breast Cancer, Breast CancerPhase 3NCT07196774
2027-12 (month only)somatrogonOPKO Health, PfizerISS, SGAPhase 3NCT07226089
2027-12 (month only)Venetoclax, Azacitidine, BL-M11D1AbbVie, Roche, Bristol-Myers SquibbAcute Myeloid LeukemiaPhase 2/3NCT07255872
2027-12 (month only)Bortezomib, Lenalidomide, SCTC21C, DexamethasoneJanssen, Takeda Pharmaceutical Company, Bristol-Myers SquibbMultiple MyelomaPhase 3NCT07297329
2027-12 (month only)HRS-4357Jiangsu Hengrui PharmaceuticalsMetastatic Castration-Resistant Prostate CancerPhase 3NCT07311694
2027-12 (month only)Bortezomib, SCTC21C, DexamethasoneJanssen, Takeda Pharmaceutical Company, Sinocelltech Group Ltd.AL AmyloidosisPhase 3NCT07388602
2027-12 (month only)Notiretatug rezetecanJiangsu Hengrui PharmaceuticalsCervical CancerPhase 3NCT07418749
2027-12 (month only)QLC7401Qilu Pharmaceutical, Suzhou Ribo Life ScienceAtherosclerotic Cardiovascular DiseasePhase 3NCT07441317
2027-12 (month only)Safiglipron (HRS-7535)Jiangsu Hengrui Pharmaceuticals, Kailera TherapeuticsObesity, HypertensionPhase 3NCT07528027
2027-12 (month only)PyrotinibDr. Reddy's Laboratories, HLB Life Science, Jiangsu Hengrui PharmaceuticalsBreast CancerPhase 3NCT07528716
2027-12 (month only)filgotinibAlfasigma, Gilead SciencesJuvenile Idiopathic Arthritis (JIA)Phase 3NCT07553182
2027-12 (month only)RoluperidoneMinerva NeurosciencesSchizophreniaPhase 3NCT07565428
2027-12 (month only)fluticasone propionateGlaxoSmithKlineChronic CoughPhase 3NCT07582549
2027-12 (month only)BofanglutideA. Menarini, Gan & Lee Pharmaceuticals, JW PharmaceuticalObesityPhase 3NCT07622810
2027-12 (month only)Trastuzumab brengitecanSichuan Baili PharmaceuticalColorectal CancerPhase 3NCT07730489
2027-12 (month only)KH607Chengdu Kanghong PharmaceuticalMajor Depressive DisorderPhase 3NCT07741240
2027-12 (month only)KH607Chengdu Kanghong PharmaceuticalMajor Depressive DisorderPhase 3NCT07741331
2027-12 (month only)SafinamideSupernus Pharmaceuticals, Zambon SpAParkinson's DiseasePhase 3NCT07761936
2027-12 (month only)Dextromethorphan/bupropionAxsome TherapeuticsSmoking CessationPhase 3NCT07766655
2027-12 (month only)Sutantatug envedotinCorbus Pharmaceuticals, CSPC Megalith BiopharmaceuticalOropharyngeal Carcinoma (OPC)Phase 3NCT07768189
2027-12 (month only)SolriamfetolAxsome Therapeutics, Pharmanovia, SK Biopharmaceuticals Co., Ltd.Attention Deficit Hyperactivity DisorderPhase 3NCT07773883
2027-12-01Chidamide, Azacitidine, EpirubicinChipscreen Biosciences, GNT Biotech & Medicals, HUYABIO International, LLC.Peripheral T-Cell LymphomaPhase 3NCT05678933
2027-12-01IvosidenibServierCholangiocarcinomaPhase 3NCT05876754
2027-12-01Nab-paclitaxel, GemcitabineBristol-Myers Squibb, Eli LillyPancreatic Ductal Adenocarcinoma, Pancreatic CancerPhase 2/3NCT06115499
2027-12-01Tambotatug pelitecanMediLink Therapeutics (Suzhou) Co., Ltd., RocheSmall Cell Lung CancerPhase 3NCT06612151
2027-12-01Tambotatug pelitecanMediLink Therapeutics (Suzhou) Co., Ltd., RocheNasopharyngeal CarcinomaPhase 3NCT06629597
2027-12-01DaraxonrasibBeOne Medicines, Revolution MedicinesNon-Small Cell Lung CancerPhase 3NCT06881784
2027-12-01Ferric derisomaltoseChina Medical System, Nippon Shinyaku, PfizerHeart FailurePhase 3NCT06929806
2027-12-01terbutaline, DexamethasoneANI Pharmaceuticals, Inc., AstraZenecaRenal ColicPhase 3NCT06980727
2027-12-01metforminPost COVID ConditionPhase 3NCT07280572
2027-12-03Budesonide/glycopyrrolate/formoterol fumarateAstraZenecaChronic Obstructive Pulmonary DiseasePhase 3NCT06283966
2027-12-04DapagliflozinAstraZeneca, Ono PharmaceuticalChronic Coronary Syndrome, Atrial FibrillationPhase 3NCT05852704
2027-12-05Doravirine, Tenofovir disoproxil fumarate (Viread)Merck & Co., Gilead SciencesHIVPhase 3NCT07075146
2027-12-06CliramitugAstraZenecaTransthyretin Amyloidosis with CardiomyopathyPhase 3NCT06183931
2027-12-12PovetaciceptVertex PharmaceuticalsIgA NephropathyPhase 3NCT07890909
2027-12-15Atezolizumab, Cetuximab, Bevacizumab, DocetaxelChugai Pharma, Roche, Eli LillyHead and Neck Squamous Cell CarcinomaPhase 2/3NCT05063552
2027-12-15AmivantamabGenmab, Johnson & JohnsonColorectal CancerPhase 3NCT06750094
2027-12-15ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceEsophageal Squamous Cell Carcinoma (ESCC)Phase 3NCT07246330
2027-12-16ecnoglutidePfizer, Sciwind BiosciencesObesityPhase 3NCT07387094
2027-12-20Toripalimab, CapecitabineCoherus BioSciences, Inc., Shanghai Junshi Bioscience, Cheplapharm Arzneimittel GmbHNasopharyngeal CarcinomaPhase 3NCT05869227
2027-12-23Calcium, magnesium, potassium and sodium oxybates (Xywav)Jazz PharmaceuticalsNarcolepsy, Idiopathic HypersomniaPhase 3NCT07625280
2027-12-24HSK39004AirNexis Therapeutics, Haisco Pharmaceutical GroupChronic Obstructive Pulmonary DiseasePhase 3NCT07634367
2027-12-26maridebart cafraglutideAmgenObesity, Type 2 DiabetesPhase 3NCT07684144
2027-12-26maridebart cafraglutideAmgenObesityPhase 3NCT07684235
2027-12-27bimekizumabUCBPalmoplantar PustulosisPhase 3NCT07219420
2027-12-27NucresiranAlnylam PharmaceuticalsTransthyretin Amyloidosis with PolyneuropathyPhase 3NCT07223203
2027-12-28ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceEsophageal Squamous Cell Carcinoma (ESCC)Phase 3NCT06952621
2027-12-30Ferric derisomaltoseChina Medical System, Nippon Shinyaku, PfizerGynecologic Cancer, Anemia, Iron-deficiencyPhase 3NCT05407987
2027-12-30BudesonideAstraZenecaEngraftment SyndromePhase 3NCT05509933
2027-12-30AbelacimabNovartisAtrial Fibrillation (AF)Phase 3NCT05712200
2027-12-30Envafolimab3D Medicines Inc., Ascletis Pharma, Glenmark Pharmaceuticals Ltd.Non-Small Cell Lung CancerPhase 3NCT06123754
2027-12-30TislelizumabBeOne MedicinesOral Squamous Cell Carcinoma, Locally Advanced Head and Neck CarcinomaPhase 3NCT06258811
2027-12-30Nintedanib (Ofev), tocilizumabBoehringer Ingelheim, Chugai Pharma, RocheSystemic SclerosisPhase 3NCT06297096
2027-12-30Semaglutide (Wegovy)Novo NordiskObesityPhase 2/3NCT06423599
2027-12-30Carfilzomib, Daratumumab, Pomalidomide, Arlocabtagene autoleucel, DexamethasoneAmgen, Ono Pharmaceutical, Johnson & JohnsonMultiple MyelomaPhase 3NCT06615479
2027-12-30Olanzapine (Zyprexa)Cheplapharm Arzneimittel GmbH, Eli LillyNausea, VomitingPhase 3NCT07208305
2027-12-30Nab-paclitaxelBristol-Myers SquibbPancreatic CancerPhase 3NCT07272109
2027-12-30CPO301Conjupro Biotherapeutics, Inc.Non-Small Cell Lung CancerPhase 3NCT07442565
2027-12-30QL2106Qilu PharmaceuticalPsoriasisPhase 3NCT07511647
2027-12-30TretinoinCheplapharm Arzneimittel GmbHImmune ThrombocytopeniaPhase 3NCT07597395
2027-12-31NivolumabBristol-Myers Squibb, Ono PharmaceuticalAnal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Margin Squamous Cell Carcinoma, Stage IIB Anal Cancer AJCC v8, Stage III Anal Cancer AJCC v8Phase 3NCT03233711
2027-12-31IncobotulinumtoxinA (Xeomin)Merz PharmaceuticalsFocal Hand DystoniaPhase 3NCT03977493
2027-12-31Disitamab VedotinPfizer, RemeGen Co., Ltd.HR+/HER2- Metastatic Breast CancerPhase 3NCT04400695
2027-12-31Daratumumab, Bortezomib, Lenalidomide, DexamethasoneJohnson & Johnson, Janssen, Takeda Pharmaceutical CompanyMultiple MyelomaPhase 3NCT04566328
2027-12-31Cladribine (MAVENCLAD®)Merck KGaAMultiple SclerosisPhase 2/3NCT04695080
2027-12-31VenetoclaxAbbVie, RocheAcute Myeloid LeukemiaPhase 2/3NCT04708054
2027-12-31GabapentinPfizer, ViatrisPain, PostoperativePhase 2/3NCT04724252
2027-12-31ZimislecelVertex PharmaceuticalsType 1 DiabetesPhase 3NCT04786262
2027-12-31TucatinibMerck & Co., PfizerColorectal Cancer, Metastatic Colorectal Cancer, Advanced Metastatic Colorectal CancerPhase 3NCT05253651
2027-12-31OcrelizumabRocheMultiple SclerosisPhase 3NCT05269004
2027-12-31HydroxychloroquineAdvanz PharmaPreeclampsiaPhase 3NCT05287321
2027-12-31Vatiquinone (PTC743)PTC TherapeuticsFriedreich AtaxiaPhase 3NCT05515536
2027-12-31Toripalimab, AxitinibCoherus BioSciences, Inc., Shanghai Junshi Bioscience, PfizerRenal Cell CarcinomaPhase 3NCT05738694
2027-12-31Ferric carboxymaltoseDaiichi Sankyo, Vifor PharmaSurgery, Liver Metastases, Liver Cancer, Pancreas Cancer, Aortic AneurysmPhase 3NCT05744219
2027-12-31Tenofovir alafenamide/emtricitabineGilead SciencesHIVPhase 3NCT05813964
2027-12-31metforminPreeclampsiaPhase 3NCT06033131
2027-12-31OlverembatinibAscentage Pharma Group Inc., Innovent BiologicsPh+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-PositivePhase 3NCT06051409
2027-12-31LurbinectedinJazz Pharmaceuticals, Luye Pharma Group, Merck KGaASmall Cell Lung CancerPhase 3NCT06496048
2027-12-31Cemiplimab, Ramucirumab, Dexamethasone, DocetaxelRegeneron Pharmaceuticals, Eli Lilly, SanofiNon-Small Cell Lung CancerPhase 2/3NCT06616584
2027-12-31BudesonideAstraZenecaCrohn Disease (CD)Phase 2/3NCT06719622
2027-12-31onabotulinumtoxinAAbbVieEsophageal Cancer Surgery, Esophagectomy, Delayed Gastric Emptying Following Procedure, Esophageal Diseases, Esophageal Achalasia, Pylorus Dysfunction, Esophageal DysmotilityPhase 2/3NCT06721520
2027-12-31Sintilimab, ApatinibInnovent Biologics, Advenchen Laboratories, Elevar Therapeutics, Inc.Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]), Neoadjuvant Therapy, Adjuvant Chemotherapy, pCR Rate, MPR, ORR,OS,PFSPhase 3NCT06925243
2027-12-31Andamertinib, VebreltinibAvistone Biotechnology, Apollomics Inc.Non-Small Cell Lung CancerPhase 3NCT06970782
2027-12-31RegorafenibBayerColorectal Cancer, Metastatic Colorectal Cancer, Advanced Metastatic Colorectal CancerPhase 3NCT06992648
2027-12-31metforminSchizophreniaPhase 3NCT07045142
2027-12-31VenetoclaxAbbVie, RocheOlder Patients, Myeloid Malignancies, Conditioning, Hematopoietic Stem Cell Transplantation (HSCT)Phase 2/3NCT07052422
2027-12-31metforminPolycystic Ovary Syndrome (PCOS)Phase 3NCT07120815
2027-12-31MethylprednisolonePfizerAcute Ischemic StrokePhase 3NCT07141303
2027-12-31FinerenoneBayerChronic Kidney DiseasePhase 3NCT07181135
2027-12-31D-cycloserine/lurasidone (NRX-101)NRx PharmaceuticalsMajor Depressive DisorderPhase 2/3NCT07227103
2027-12-31JMKX001899HUYABIO International, LLC., JemincareNon-Small Cell Lung CancerPhase 3NCT07242274
2027-12-31LetrozoleNovartisEndometrial Cancer, FertilityPhase 2/3NCT07319429
2027-12-31Tazbentetol (SPG302)SpinogenixAmyotrophic Lateral SclerosisPhase 2/3NCT07325591
2027-12-31Nab-paclitaxelBristol-Myers SquibbHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 2/3NCT07410169
2027-12-31RC148AbbVie, RemeGen Co., Ltd.Non-Small Cell Lung CancerPhase 3NCT07416474
2027-12-31SYH2053CSPC Pharmaceutical GroupAtherosclerotic Cardiovascular DiseasePhase 3NCT07421284
2027-12-31SYH2053CSPC Pharmaceutical GroupAtherosclerotic Cardiovascular DiseasePhase 3NCT07421297
2027-12-31Rimegepant (Nurtec ODT)Eisai, PfizerDizzinessPhase 2/3NCT07435090
2027-12-31Beruzatatug pelitecanBioNTech, MediLink Therapeutics (Suzhou) Co., Ltd.HR+/HER2- Metastatic Breast CancerPhase 3NCT07461454
2027-12-31Sintilimab, Bevacizumab, CapecitabineInnovent Biologics, Roche, Cheplapharm Arzneimittel GmbHHepatocellular CarcinomaPhase 2/3NCT07490262
2027-12-31Ruxolitinib (Jakafi)Incyte, NovartisTransplant-Related DisorderPhase 3NCT07588945
2027-12-31MethylprednisolonePfizerAchilles Tendinopathy (AT)Phase 3NCT07650396
2027-12-31Camrelizumab, Afatinib, Apatinib, Toripalimab, Pyrotinib, DalpiciclibElevar Therapeutics, Inc., Jiangsu Hengrui Pharmaceuticals, Boehringer IngelheimEsophageal Squamous Cell CarcinomaPhase 2/3NCT07653451
2027-12-31EnlonstobartCSPC ZhongQi Pharmaceutical Technology Co., Ltd., Hangzhou Sumgen Biotech Co., Ltd.Non-Small Cell Lung CancerPhase 2/3NCT07662811
2027-12-31Efgartigimod alfa and hyaluronidase (Vyvgart Hytrulo)argenxStiff Person SyndromePhase 2/3NCT07860021
2027-12-31nemolizumabChugai Pharma, Galderma, MaruhoDystrophic Epidermolysis BullosaPhase 2/3NCT07926867
2027-12-31Sintilimab, CapecitabineInnovent Biologics, Cheplapharm Arzneimittel GmbHEarly Low Rectal CancerPhase 3NCT07933679

Source: ClinicalTrials.gov, each study's record, checked daily. Studies that are terminated, withdrawn or completed are left out, as are programmes their developer has stopped. A month-only date is shown as given.